1827 files analyzed (sorted by compliance, lowest first)
Showing the 10 files with lowest compliance for prioritized curation.
Files with lowest compliance are listed first to prioritize curation efforts.
| File | Global | Weighted | Populated | Violations |
|---|---|---|---|---|
#1 Rasmussen_Encephalitis.yaml |
41.0% | 53.5% | 25/61 | 1 |
#2 SCN2A-Related_Developmental_and_Epileptic_Encephalopathy.yaml |
42.3% | 53.7% | 30/71 | 1 |
#3 Sturge-Weber_Syndrome.yaml |
43.9% | 56.0% | 50/114 | 1 |
#4 Epilepsy_with_Myoclonic_Atonic_Seizures.yaml |
44.0% | 55.6% | 33/75 | 1 |
#5 Lennox-Gastaut_Syndrome.yaml |
45.1% | 53.7% | 46/102 | 2 |
#6 Childhood_Absence_Epilepsy.yaml |
45.2% | 56.5% | 42/93 | 1 |
#7 Juvenile_Myoclonic_Epilepsy.yaml |
45.8% | 57.1% | 33/72 | 1 |
#8 SCN8A-Related_Developmental_and_Epileptic_Encephalopathy.yaml |
46.4% | 58.4% | 32/69 | 1 |
#9 Self-Limited_Epilepsy_with_Centrotemporal_Spikes.yaml |
47.2% | 54.7% | 34/72 | 2 |
#10 Epilepsy_of_Infancy_with_Migrating_Focal_Seizures.yaml |
48.7% | 60.7% | 38/78 | 1 |
Febrile_Infection-Related_Epilepsy_Syndrome.yaml |
48.8% | 61.8% | 62/127 | 1 |
Gerstmann-Straussler-Scheinker_Syndrome.yaml |
51.6% | 64.3% | 64/124 | 1 |
GNAO1-Related_Developmental_and_Epileptic_Encephalopathy.yaml |
52.4% | 64.8% | 65/124 | 1 |
Vici_Syndrome.yaml |
54.1% | 68.6% | 79/146 | |
PPP2R3C-Related_Gonadal_Dysgenesis_Syndrome.yaml |
54.1% | 70.3% | 98/181 | |
PCDH19_Clustering_Epilepsy.yaml |
55.2% | 60.5% | 48/87 | 2 |
Acute_Post-Surgical_Pain.yaml |
55.4% | 70.2% | 41/74 | |
Cerebral_Palsy.yaml |
55.7% | 69.0% | 97/174 | 1 |
Mabry_Syndrome.yaml |
56.8% | 68.5% | 105/185 | 1 |
Pyridoxine-Dependent_Epilepsy.yaml |
57.8% | 62.4% | 52/90 | 3 |
ZNF407-Related_Neurodevelopmental_Disorder.yaml |
58.8% | 75.3% | 67/114 | |
Short_Stature_Microcephaly_and_Endocrine_Dysfunction.yaml |
60.0% | 75.0% | 30/50 | |
PNPO_Deficiency.yaml |
60.7% | 63.9% | 54/89 | 3 |
CDKL5_Deficiency_Disorder.yaml |
62.0% | 67.8% | 75/121 | 2 |
Major_Depressive_Disorder.yaml |
62.8% | 64.7% | 147/234 | 2 |
PRMT7-Related_Short_Stature-Brachydactyly_Syndrome.yaml |
63.3% | 78.3% | 50/79 | |
STX1B-Related_Epilepsy.yaml |
63.4% | 65.3% | 52/82 | 2 |
Chronic_Kidney_Disease.yaml |
63.4% | 66.5% | 85/134 | |
FGFR_Altered_Cholangiocarcinoma.yaml |
63.5% | 67.9% | 54/85 | 1 |
Alveolar_Rhabdomyosarcoma.yaml |
63.9% | 62.9% | 204/319 | 3 |
CPLX1-Related_DEE.yaml |
64.4% | 66.7% | 56/87 | 2 |
KCNQ2_Developmental_and_Epileptic_Encephalopathy.yaml |
64.6% | 68.5% | 53/82 | 2 |
Familial_Atrial_Fibrillation.yaml |
64.8% | 70.3% | 70/108 | |
Hepatocellular_Carcinoma.yaml |
64.9% | 65.8% | 124/191 | 3 |
Pinta.yaml |
65.0% | 69.1% | 13/20 | |
Aflatoxin_Related_HCC.yaml |
65.1% | 66.5% | 112/172 | |
DNM1_Encephalopathy.yaml |
65.2% | 67.2% | 60/92 | 2 |
IDH_Mutant_Astrocytoma.yaml |
65.2% | 68.8% | 45/69 | 1 |
IDH_Mutant_Cholangiocarcinoma.yaml |
65.4% | 68.5% | 53/81 | 1 |
Gastroesophageal_Reflux_Disease.yaml |
65.6% | 70.7% | 40/61 | |
Uveal_Melanoma.yaml |
65.6% | 67.1% | 63/96 | 1 |
Osteoporosis.yaml |
65.8% | 67.3% | 79/120 | 1 |
HER2_Positive_Gastric_Cancer.yaml |
66.3% | 70.6% | 57/86 | 1 |
Allergic_Cutaneous_Vasculitis.yaml |
66.3% | 68.4% | 67/101 | |
SYNGAP1-Related_Developmental_and_Epileptic_Encephalopathy.yaml |
66.4% | 71.0% | 71/107 | 2 |
Li-Fraumeni_Syndrome.yaml |
66.5% | 68.8% | 111/167 | 1 |
CRADD-Related_Thin_Lissencephaly.yaml |
66.7% | 71.1% | 40/60 | 1 |
Diffuse_Large_B_Cell_Lymphoma.yaml |
66.7% | 70.0% | 74/111 | 1 |
Gastrointestinal_Stromal_Tumor.yaml |
66.7% | 72.3% | 40/60 | 1 |
Generalized_Anxiety_Disorder.yaml |
66.7% | 72.8% | 54/81 | |
Multiple_Endocrine_Neoplasia_Type_2.yaml |
66.7% | 69.5% | 50/75 | 1 |
Pheochromocytoma_Paraganglioma.yaml |
66.7% | 69.1% | 62/93 | 1 |
Primary_Biliary_Cholangitis.yaml |
66.7% | 70.0% | 32/48 | |
Primary_Sclerosing_Cholangitis.yaml |
66.7% | 72.8% | 30/45 | |
Retinoblastoma.yaml |
66.7% | 72.5% | 40/60 | 1 |
SNAP25_Encephalopathy.yaml |
67.0% | 69.1% | 63/94 | 2 |
Multiple_Synostoses_Syndrome.yaml |
67.1% | 72.5% | 47/70 | |
Triglyceride_Storage_Disease_Type_1.yaml |
67.2% | 75.9% | 41/61 | |
Fibromyalgia.yaml |
67.3% | 71.7% | 72/107 | |
Alpha_1_Antitrypsin_Deficiency.yaml |
67.4% | 68.5% | 149/221 | 1 |
Kaposi_Sarcoma.yaml |
67.4% | 69.9% | 58/86 | 1 |
HIDEA_Syndrome.yaml |
67.5% | 72.9% | 54/80 | 1 |
IDH_Mutant_Oligodendroglioma.yaml |
67.5% | 69.3% | 54/80 | 1 |
Glioblastoma_IDH_Wildtype.yaml |
67.6% | 69.3% | 75/111 | 1 |
HPV_Negative_Head_and_Neck_Cancer.yaml |
67.6% | 69.7% | 75/111 | 1 |
Mixed_Germ_Cell_Tumor.yaml |
67.6% | 72.5% | 73/108 | |
Human_Metapneumovirus_Infection.yaml |
67.7% | 80.7% | 21/31 | |
Essential_Thrombocythemia.yaml |
67.8% | 79.3% | 118/174 | |
Camptodactyly.yaml |
68.0% | 71.3% | 51/75 | 1 |
IDH_Mutant_AML.yaml |
68.0% | 70.2% | 66/97 | 1 |
RET_Fusion_Thyroid_Cancer.yaml |
68.1% | 70.3% | 49/72 | 1 |
Spinocerebellar_Ataxia_Type_15_16.yaml |
68.1% | 73.8% | 32/47 | 1 |
Desmoplastic_Small_Round_Cell_Tumor.yaml |
68.1% | 72.1% | 47/69 | |
Triple_Negative_Breast_Cancer.yaml |
68.1% | 70.9% | 47/69 | 1 |
Alopecia_Areata.yaml |
68.2% | 69.3% | 30/44 | |
Hereditary_Spastic_Paraplegia_48.yaml |
68.2% | 76.0% | 30/44 | |
Coronary_Artery_Disease.yaml |
68.2% | 70.4% | 73/107 | 2 |
FGFR_Altered_Urothelial_Carcinoma.yaml |
68.3% | 70.3% | 41/60 | 1 |
Frontotemporal_Dementia.yaml |
68.3% | 70.4% | 41/60 | 1 |
Bronchiectasis.yaml |
68.4% | 72.8% | 80/117 | 1 |
Atypical_Hemolytic_Uremic_Syndrome.yaml |
68.5% | 69.6% | 148/216 | |
Peripheral_Artery_Disease.yaml |
68.6% | 74.0% | 48/70 | |
Beta_Thalassemia.yaml |
69.0% | 74.5% | 118/171 | |
HER2_Positive_Colorectal_Cancer.yaml |
69.0% | 76.7% | 58/84 | 1 |
Q_Fever.yaml |
69.4% | 77.7% | 43/62 | |
Oral_Cavity_Squamous_Cell_Carcinoma.yaml |
69.4% | 74.2% | 68/98 | |
Juvenile_Idiopathic_Arthritis.yaml |
69.6% | 79.4% | 117/168 | 1 |
Warburg_Micro_Syndrome.yaml |
69.7% | 75.0% | 122/175 | |
Medulloblastoma_WNT_Activated.yaml |
69.7% | 71.4% | 53/76 | 1 |
Senior-Loken_Syndrome.yaml |
69.7% | 79.4% | 106/152 | |
SRPX2-related_Speech_Epilepsy_Polymicrogyria.yaml |
70.0% | 73.1% | 77/110 | 2 |
Heyn-Sproul-Jackson_syndrome.yaml |
70.1% | 73.9% | 47/67 | 1 |
SNF8-Related_Neurodevelopmental_Disorder.yaml |
70.1% | 75.0% | 94/134 | |
Primary_Ciliary_Dyskinesia_47_and_Lissencephaly.yaml |
70.2% | 74.6% | 73/104 | |
TP63_Ectodermal_Dysplasia_Spectrum.yaml |
70.3% | 74.9% | 71/101 | 1 |
Infantile_Myofibromatosis.yaml |
70.5% | 79.8% | 31/44 | |
Danon_disease.yaml |
70.5% | 78.2% | 122/173 | |
Keratosis_Follicularis_Spinulosa_Decalvans.yaml |
70.7% | 77.7% | 118/167 | |
Mesial_Temporal_Lobe_Epilepsy_with_Hippocampal_Sclerosis.yaml |
70.8% | 71.6% | 51/72 | 1 |
Pancreatic_Ductal_Adenocarcinoma.yaml |
71.1% | 74.0% | 133/187 | 3 |
Autosomal_Dominant_Polycystic_Kidney_Disease.yaml |
71.2% | 78.8% | 156/219 | |
Cervical_Cancer.yaml |
71.3% | 75.3% | 77/108 | |
Hepatitis_C.yaml |
71.4% | 75.8% | 45/63 | 1 |
Type_2_Diabetes_Mellitus.yaml |
71.7% | 74.9% | 137/191 | 2 |
Rhinovirus_Infection.yaml |
71.9% | 79.3% | 23/32 | |
Ewing_Sarcoma.yaml |
72.0% | 72.3% | 303/421 | 2 |
Immune_Thrombocytopenia.yaml |
72.0% | 78.5% | 36/50 | |
Nasopharyngeal_Carcinoma.yaml |
72.0% | 74.5% | 72/100 | 1 |
FLNA_Intestinal_Pseudoobstruction.yaml |
72.1% | 75.4% | 44/61 | |
NTRK_Fusion_Positive_Cancer.yaml |
72.1% | 73.6% | 44/61 | 1 |
Autoimmune_Retinopathy.yaml |
72.2% | 75.8% | 57/79 | |
Malignant_Mesothelioma.yaml |
72.2% | 76.0% | 57/79 | 1 |
Gastric_Ulcer.yaml |
72.2% | 73.9% | 13/18 | |
Sengers_syndrome.yaml |
72.3% | 79.8% | 99/137 | |
Central_Nervous_System_Germ_Cell_Tumor.yaml |
72.3% | 70.5% | 136/188 | 2 |
Diffuse_Astrocytoma.yaml |
72.4% | 77.2% | 63/87 | |
Glycoprotein_Storage_Disease.yaml |
72.4% | 79.4% | 42/58 | |
Terminal_Osseous_Dysplasia.yaml |
72.8% | 78.2% | 75/103 | |
KRAS_G12C_Mutant_NSCLC.yaml |
72.8% | 75.0% | 59/81 | 1 |
Chronic_Lymphocytic_Leukemia.yaml |
72.9% | 74.9% | 78/107 | 1 |
Focal_Segmental_Glomerulosclerosis.yaml |
72.9% | 75.8% | 113/155 | 1 |
Pfeiffer_Syndrome.yaml |
72.9% | 80.6% | 70/96 | |
Primary_Myelofibrosis.yaml |
73.0% | 80.1% | 154/211 | 1 |
Autosomal_Dominant_Osteopetrosis_Type_II.yaml |
73.0% | 77.3% | 92/126 | |
HPV_Positive_Head_and_Neck_Cancer.yaml |
73.1% | 75.4% | 57/78 | 1 |
Metastatic_Melanoma.yaml |
73.2% | 75.7% | 60/82 | 1 |
Timothy_Syndrome.yaml |
73.2% | 75.4% | 104/142 | 4 |
BRAF_Mutant_Thyroid_Cancer.yaml |
73.3% | 74.6% | 63/86 | 1 |
Gastric_Cancer_H_pylori_Associated.yaml |
73.3% | 76.8% | 85/116 | |
Diamond-Blackfan_Anemia.yaml |
73.3% | 76.0% | 88/120 | |
Heart_Failure.yaml |
73.3% | 77.4% | 66/90 | |
Mycoplasma_Pneumoniae_Pneumonia.yaml |
73.5% | 78.6% | 25/34 | |
You-Hoover-Fong_Syndrome.yaml |
73.6% | 79.1% | 39/53 | |
Laryngeal_Squamous_Cell_Carcinoma.yaml |
73.6% | 77.0% | 81/110 | |
Drug_or_Toxin-Induced_Pulmonary_Arterial_Hypertension.yaml |
73.7% | 75.7% | 56/76 | 2 |
Respiratory_Syncytial_Virus_Infection.yaml |
73.8% | 81.5% | 31/42 | |
Autoimmune_Hemolytic_Anemia.yaml |
73.9% | 78.4% | 34/46 | |
Charcot-Marie-Tooth_Disease.yaml |
73.9% | 77.2% | 34/46 | |
Psoriasis.yaml |
73.9% | 76.2% | 139/188 | 1 |
Benign_Prostatic_Hyperplasia.yaml |
74.1% | 77.6% | 60/81 | 1 |
MSI_High_Endometrial_Cancer.yaml |
74.1% | 75.9% | 60/81 | 1 |
Metastatic_Renal_Cell_Carcinoma.yaml |
74.1% | 75.9% | 63/85 | |
STXBP1_Encephalopathy.yaml |
74.1% | 76.0% | 109/147 | 2 |
Clear_Cell_Renal_Cell_Carcinoma.yaml |
74.2% | 77.8% | 66/89 | 1 |
Dystroglycanopathy.yaml |
74.2% | 79.2% | 198/267 | 2 |
Crouzon_Syndrome_with_Acanthosis_Nigricans.yaml |
74.2% | 79.0% | 69/93 | |
Netherton_Syndrome.yaml |
74.3% | 80.0% | 153/206 | |
Cystinosis.yaml |
74.3% | 83.4% | 335/451 | |
Aminoacylase_1_Deficiency.yaml |
74.3% | 76.7% | 52/70 | |
Alport_Syndrome.yaml |
74.3% | 74.9% | 194/261 | 1 |
Granular_Cell_Tumor.yaml |
74.4% | 78.5% | 58/78 | |
Thanatophoric_Dysplasia_Type_1.yaml |
74.4% | 76.2% | 163/219 | |
Chronic_Myeloid_Leukemia.yaml |
74.6% | 76.1% | 97/130 | 2 |
Chronic_Intestinal_Pseudoobstruction.yaml |
74.6% | 78.6% | 50/67 | |
Hyperlipidemia.yaml |
74.6% | 81.5% | 150/201 | 1 |
Atopic_Dermatitis.yaml |
74.7% | 76.9% | 127/170 | 2 |
PKP2_Cardiomyopathy.yaml |
74.8% | 78.6% | 77/103 | |
Bipolar_Disorder.yaml |
75.0% | 77.9% | 81/108 | 1 |
Cutaneous_Squamous_Cell_Carcinoma.yaml |
75.0% | 78.4% | 60/80 | |
Familial_Partial_Lipodystrophy.yaml |
75.0% | 79.8% | 96/128 | |
Jeune_Asphyxiating_Thoracic_Dystrophy.yaml |
75.0% | 76.5% | 123/164 | |
Langerhans_Cell_Histiocytosis.yaml |
75.0% | 79.6% | 60/80 | |
Metastatic_Prostate_Cancer.yaml |
75.0% | 75.7% | 66/88 | 1 |
Obstructive_Sleep_Apnea.yaml |
75.0% | 78.2% | 75/100 | 1 |
Pneumococcal_Pneumonia.yaml |
75.0% | 80.3% | 27/36 | |
Autosomal_Recessive_Osteopetrosis.yaml |
75.2% | 78.5% | 115/153 | 1 |
Baraitser-Winter_Cerebrofrontofacial_Syndrome.yaml |
75.2% | 78.5% | 106/141 | 2 |
Small_Cell_Lung_Cancer.yaml |
75.2% | 78.6% | 85/113 | |
Osteogenesis_Imperfecta_Type_I.yaml |
75.2% | 79.8% | 76/101 | |
Influenza.yaml |
75.3% | 83.3% | 64/85 | |
Merkel_Cell_Carcinoma.yaml |
75.3% | 78.1% | 64/85 | 1 |
Progressive_Myoclonus_Epilepsy.yaml |
75.3% | 78.3% | 64/85 | 1 |
Osteopetrosis.yaml |
75.3% | 78.7% | 113/150 | |
Autoimmune_Encephalitis.yaml |
75.3% | 78.6% | 55/73 | 1 |
NAGA_Deficiency_Type_3.yaml |
75.4% | 80.8% | 52/69 | |
Osteogenesis_Imperfecta_Type_II.yaml |
75.4% | 79.5% | 92/122 | 1 |
Ellis-van_Creveld_Syndrome.yaml |
75.4% | 80.2% | 89/118 | |
Dravet_syndrome.yaml |
75.4% | 77.4% | 258/342 | 2 |
Liver_Cirrhosis.yaml |
75.5% | 78.5% | 83/110 | |
SYN1-Related_Disorder.yaml |
75.6% | 80.0% | 34/45 | |
Mixed_Connective_Tissue_Disease.yaml |
75.6% | 80.1% | 31/41 | |
Obesity.yaml |
75.7% | 78.9% | 84/111 | |
Postpoliomyelitis_Syndrome.yaml |
75.7% | 85.5% | 53/70 | |
Psoriatic_Arthritis.yaml |
75.7% | 83.3% | 53/70 | 1 |
Osteoarthritis.yaml |
75.8% | 78.3% | 75/99 | 1 |
HER2_Positive_Breast_Cancer.yaml |
75.8% | 76.9% | 72/95 | 2 |
Charcot-Marie-Tooth_Disease-Hearing_Loss-Intellectual_Disability_Syndrome.yaml |
75.8% | 80.1% | 47/62 | |
Delpire-McNeill_Syndrome.yaml |
75.8% | 80.8% | 94/124 | |
Hand-Foot-Genital_Syndrome.yaml |
75.8% | 77.5% | 47/62 | |
Primary_Ciliary_Dyskinesia.yaml |
75.8% | 80.7% | 317/418 | |
Dilated_Cardiomyopathy_1AA.yaml |
75.8% | 80.4% | 179/236 | |
Seasonal_Coronavirus_Infection.yaml |
75.9% | 83.3% | 22/29 | |
Sickle_Cell_Disease.yaml |
75.9% | 77.0% | 151/199 | |
Inherited_Ichthyosis.yaml |
75.9% | 79.2% | 107/141 | |
KCNB1-Related_Developmental_and_Epileptic_Encephalopathy.yaml |
75.9% | 78.3% | 107/141 | 2 |
Pertussis.yaml |
75.9% | 83.0% | 63/83 | |
Gorham-Stout_disease.yaml |
75.9% | 79.2% | 41/54 | 1 |
PARK7-Related_Early-Onset_Parkinson_Disease.yaml |
76.0% | 75.8% | 158/208 | 2 |
Neuroblastoma.yaml |
76.0% | 78.3% | 73/96 | 1 |
Pouchitis.yaml |
76.1% | 81.7% | 35/46 | |
DSP_Cardiomyopathy.yaml |
76.1% | 79.2% | 51/67 | 1 |
Temtamy_Preaxial_Brachydactyly_Syndrome.yaml |
76.1% | 80.5% | 118/155 | 1 |
PCWH_syndrome.yaml |
76.2% | 80.1% | 64/84 | 1 |
Viral_Encephalitis.yaml |
76.2% | 79.4% | 96/126 | |
Cockayne_Syndrome.yaml |
76.2% | 80.2% | 231/303 | |
Alpha_Thalassemia.yaml |
76.3% | 79.9% | 106/139 | |
Gallbladder_Cancer.yaml |
76.3% | 80.2% | 106/139 | |
Spinal_Muscular_Atrophy.yaml |
76.3% | 78.0% | 193/253 | 3 |
Endometriosis.yaml |
76.3% | 78.7% | 145/190 | 1 |
Parainfluenza_Virus_Infection.yaml |
76.3% | 82.6% | 29/38 | |
Testicular_Germ_Cell_Tumor.yaml |
76.3% | 78.5% | 58/76 | |
Aicardi_Syndrome.yaml |
76.4% | 79.7% | 113/148 | |
Metastatic_NSCLC.yaml |
76.4% | 77.9% | 68/89 | 1 |
COX18-Related_COX_Deficiency.yaml |
76.5% | 80.7% | 26/34 | |
Campylobacteriosis.yaml |
76.5% | 83.1% | 143/187 | |
Neutral_Lipid_Storage_Myopathy.yaml |
76.5% | 81.6% | 39/51 | |
Polycystic_Ovary_Syndrome.yaml |
76.5% | 77.5% | 166/217 | 1 |
Tooth_Agenesis.yaml |
76.5% | 79.4% | 88/115 | |
Ulcerative_Colitis.yaml |
76.6% | 78.4% | 157/205 | 1 |
Oculopharyngodistal_Myopathy.yaml |
76.6% | 79.2% | 72/94 | 1 |
FICUS_syndrome.yaml |
76.6% | 86.1% | 59/77 | |
Chromosome_18p_Deletion_Syndrome.yaml |
76.7% | 80.3% | 89/116 | |
Mucolipidosis_Type_II.yaml |
76.8% | 81.4% | 73/95 | |
Pulmonary_hypertension.yaml |
76.9% | 81.0% | 93/121 | |
Central_Areolar_Choroidal_Dystrophy.yaml |
77.0% | 81.1% | 67/87 | |
Chronic_Beryllium_Disease.yaml |
77.0% | 81.9% | 94/122 | |
Dorfman_Chanarin_Disease.yaml |
77.0% | 82.7% | 47/61 | |
Erdheim-Chester_Disease.yaml |
77.0% | 86.2% | 47/61 | |
Systemic_Mastocytosis.yaml |
77.1% | 80.6% | 74/96 | |
Bazex_Dupre_Christol_Syndrome.yaml |
77.1% | 78.7% | 108/140 | |
Cervical_Squamous_Cell_Carcinoma.yaml |
77.2% | 81.1% | 44/57 | |
Autism_Spectrum_Disorder.yaml |
77.2% | 80.5% | 78/101 | |
Autosomal_Dominant_Optic_Atrophy_Plus.yaml |
77.3% | 78.9% | 68/88 | 1 |
Shprintzen-Goldberg_Syndrome.yaml |
77.3% | 83.6% | 58/75 | |
Campomelic_Dysplasia.yaml |
77.4% | 79.9% | 106/137 | |
Hutchinson-Gilford_Progeria_Syndrome.yaml |
77.5% | 79.7% | 62/80 | |
Gastroenteropancreatic_Neuroendocrine_Neoplasm.yaml |
77.5% | 81.3% | 100/129 | |
Congenital_Zika_Syndrome.yaml |
77.5% | 81.4% | 69/89 | 2 |
IgG4-Related_Disease.yaml |
77.6% | 79.4% | 114/147 | 1 |
CASQ2_CPVT.yaml |
77.7% | 79.1% | 171/220 | 1 |
IgA_Nephropathy.yaml |
78.0% | 82.8% | 135/173 | |
Medulloblastoma.yaml |
78.0% | 83.3% | 32/41 | |
Warsaw_breakage_syndrome.yaml |
78.0% | 80.2% | 64/82 | |
Spondylometaphyseal_Dysplasia_Kozlowski_Type.yaml |
78.1% | 81.8% | 121/155 | |
Autoimmune_Polyendocrine_Syndrome_Type_1.yaml |
78.1% | 80.7% | 114/146 | |
COX4I2-Related_Pancreatic_Insufficiency-Anemia-Hyperostosis_Syndrome.yaml |
78.2% | 81.7% | 43/55 | |
KATNB1-related_Cortical_Malformation.yaml |
78.3% | 81.8% | 90/115 | 2 |
GABRG2-Related_Epilepsy.yaml |
78.3% | 81.3% | 101/129 | 1 |
GM1_Gangliosidosis_Type_1.yaml |
78.3% | 81.6% | 141/180 | |
Volumetric_Muscle_Loss.yaml |
78.4% | 81.6% | 91/116 | 1 |
Coffin-Lowry_Syndrome.yaml |
78.5% | 79.6% | 51/65 | |
Epithelioid_Sarcoma.yaml |
78.5% | 81.2% | 51/65 | 1 |
MSI_High_Colorectal_Cancer.yaml |
78.5% | 80.5% | 84/107 | |
PET100-Related_COX_Deficiency.yaml |
78.5% | 81.0% | 84/107 | |
Cranioectodermal_Dysplasia.yaml |
78.5% | 80.8% | 128/163 | |
Autoimmune_Gastritis.yaml |
78.7% | 80.7% | 107/136 | |
Distal_Hereditary_Motor_Neuronopathy_Autosomal_Recessive.yaml |
78.7% | 80.9% | 74/94 | |
GM1_Gangliosidosis_Type_3.yaml |
78.7% | 84.4% | 37/47 | |
Osteogenesis_Imperfecta_Type_III.yaml |
78.7% | 82.6% | 100/127 | |
Deficiency_of_Adenosine_Deaminase_2.yaml |
78.8% | 81.7% | 89/113 | |
Hereditary_Spherocytosis.yaml |
78.8% | 81.3% | 160/203 | |
Fontaine_Progeroid_Syndrome.yaml |
78.9% | 81.0% | 254/322 | |
Osteoglophonic_Dysplasia.yaml |
78.9% | 82.1% | 101/128 | |
EDAR_Hypohidrotic_Ectodermal_Dysplasia.yaml |
78.9% | 80.6% | 116/147 | |
Huntington_Disease.yaml |
78.9% | 79.5% | 345/437 | 4 |
Sarcoma_Of_Cervix_Uteri.yaml |
78.9% | 83.1% | 75/95 | |
TUBA1A-related_Tubulinopathy.yaml |
78.9% | 81.2% | 60/76 | 2 |
Stickler_Syndrome_Type_1.yaml |
79.0% | 80.9% | 139/176 | 1 |
EDARADD_Hypohidrotic_Ectodermal_Dysplasia.yaml |
79.0% | 81.1% | 79/100 | |
Crohn_Disease.yaml |
79.0% | 79.3% | 305/386 | 4 |
Autosomal_Recessive_Congenital_Ichthyosis.yaml |
79.0% | 82.6% | 132/167 | |
Silicosis.yaml |
79.1% | 83.1% | 87/110 | |
COVID-19.yaml |
79.2% | 80.6% | 114/144 | 2 |
Generalized_Epilepsy_with_Febrile_Seizures_Plus.yaml |
79.2% | 80.2% | 133/168 | 1 |
KIT_Mutant_Melanoma.yaml |
79.2% | 81.5% | 76/96 | |
Inherited_Aplastic_Anemia.yaml |
79.2% | 82.2% | 118/149 | |
Furunculosis.yaml |
79.2% | 87.0% | 99/125 | |
Type_I_Diabetes.yaml |
79.2% | 78.1% | 244/308 | 7 |
Miller-Dieker_Lissencephaly_Syndrome.yaml |
79.3% | 81.6% | 107/135 | 1 |
GNAS-related_pituitary_adenoma_3.yaml |
79.3% | 84.0% | 65/82 | |
Trachoma.yaml |
79.3% | 80.3% | 23/29 | |
TUBB_TUBB5-related_Microcephaly.yaml |
79.3% | 82.6% | 73/92 | 2 |
Cervical_Adenocarcinoma.yaml |
79.4% | 82.5% | 50/63 | |
Osteogenesis_Imperfecta_Type_XXIII.yaml |
79.4% | 82.4% | 50/63 | 1 |
FOXG1_Disorder.yaml |
79.4% | 82.1% | 177/223 | |
SHH_Holoprosencephaly_Spectrum.yaml |
79.4% | 82.1% | 54/68 | |
Snijders_Blok-Campeau_Syndrome.yaml |
79.5% | 82.1% | 116/146 | |
Muenke_Syndrome.yaml |
79.5% | 82.6% | 62/78 | |
Ankylosing_Spondylitis.yaml |
79.5% | 81.9% | 132/166 | |
Zimmermann_Laband_Syndrome.yaml |
79.5% | 82.0% | 202/254 | |
Neurofibroma.yaml |
79.5% | 83.2% | 70/88 | |
Boutonneuse_Fever.yaml |
79.6% | 81.2% | 179/225 | |
H3_K27_Altered_Diffuse_Midline_Glioma.yaml |
79.6% | 80.7% | 74/93 | 1 |
X-linked_Hypohidrotic_Ectodermal_Dysplasia.yaml |
79.6% | 82.1% | 113/142 | |
Core_Binding_Factor_AML.yaml |
79.6% | 83.6% | 78/98 | |
Multiple_Sulfatase_Deficiency.yaml |
79.6% | 80.6% | 195/245 | |
Plague.yaml |
79.6% | 83.0% | 82/103 | |
DeSanto-Shinawi_Syndrome.yaml |
79.6% | 80.4% | 43/54 | |
SDHA-Related_Neurodegeneration_With_Ataxia_And_Optic_Atrophy.yaml |
79.6% | 81.6% | 180/226 | |
Cardiofaciocutaneous_Syndrome.yaml |
79.7% | 84.3% | 55/69 | |
COPA_Syndrome.yaml |
79.7% | 81.2% | 181/227 | |
pseudotumor_cerebri.yaml |
79.8% | 81.4% | 87/109 | 1 |
Porphyria_due_to_ALA_Dehydratase_Deficiency.yaml |
79.9% | 85.7% | 159/199 | |
Duane_Radial_Ray_Syndrome.yaml |
80.0% | 81.9% | 140/175 | |
Dupuytrens_Contracture.yaml |
80.0% | 81.3% | 68/85 | 1 |
Episodic_Ataxia.yaml |
80.0% | 82.9% | 60/75 | 1 |
NPM1_Mutant_AML.yaml |
80.0% | 81.6% | 72/90 | 1 |
Pitt-Hopkins_Syndrome.yaml |
80.0% | 83.0% | 56/70 | |
SCO1-Related_COX_Deficiency.yaml |
80.0% | 83.7% | 32/40 | |
TACO1-Related_COX_Deficiency.yaml |
80.0% | 83.4% | 36/45 | |
Twin_to_Twin_Transfusion_Syndrome.yaml |
80.0% | 81.3% | 84/105 | |
Esophageal_Atresia.yaml |
80.1% | 86.0% | 149/186 | |
Myoclonus_Dystonia_Syndrome.yaml |
80.1% | 81.8% | 121/151 | |
Neuromyelitis_Optica_Spectrum_Disorder_with_Anti-AQP4_Antibodies.yaml |
80.1% | 81.3% | 117/146 | 1 |
ADPRS-Related_Stress-Induced_Neurodegeneration.yaml |
80.1% | 81.8% | 230/287 | 1 |
Osteogenesis_Imperfecta_Type_XXI.yaml |
80.3% | 83.5% | 61/76 | 1 |
Unverricht-Lundborg_Disease.yaml |
80.3% | 81.6% | 122/152 | 2 |
Distal_Myopathy_6_Adult-Onset_Autosomal_Dominant.yaml |
80.3% | 82.1% | 57/71 | 1 |
KCNA2-Related_Developmental_and_Epileptic_Encephalopathy.yaml |
80.3% | 82.1% | 110/137 | 2 |
Esophageal_Squamous_Cell_Carcinoma.yaml |
80.3% | 83.2% | 106/132 | |
Sclerosing_Cholangitis.yaml |
80.4% | 82.8% | 131/163 | |
BEST1_Bestrophinopathies.yaml |
80.4% | 83.3% | 82/102 | |
Dermoid_Cyst.yaml |
80.4% | 82.9% | 82/102 | |
Distal_Hereditary_Motor_Neuronopathy_Autosomal_Dominant.yaml |
80.4% | 82.1% | 82/102 | |
Atrial_Fibrillation.yaml |
80.5% | 81.8% | 99/123 | 1 |
Cholangiocarcinoma.yaml |
80.5% | 83.1% | 66/82 | |
Stankiewicz_Isidor_syndrome.yaml |
80.5% | 82.7% | 66/82 | |
Niemann-Pick_Disease_Type_B.yaml |
80.6% | 84.8% | 58/72 | |
Loeys-Dietz_Syndrome.yaml |
80.6% | 82.2% | 204/253 | |
Behr_Syndrome.yaml |
80.7% | 82.8% | 142/176 | |
Cytomegalovirus_Retinitis.yaml |
80.7% | 84.7% | 71/88 | |
Small_Intestine_Cancer.yaml |
80.7% | 83.9% | 92/114 | |
angioosteohypertrophic_syndrome.yaml |
80.7% | 83.6% | 46/57 | |
NDE1-related_Microcephaly_Lissencephaly.yaml |
80.7% | 83.9% | 88/109 | 2 |
Inherited_Retinal_Dystrophy.yaml |
80.8% | 84.0% | 80/99 | 1 |
Minimal_Change_Disease.yaml |
80.8% | 82.6% | 156/193 | |
Oroya_Fever.yaml |
80.8% | 82.5% | 97/120 | |
COX20-Related_COX_Deficiency.yaml |
80.9% | 83.7% | 38/47 | |
Metastatic_Breast_Carcinoma.yaml |
80.9% | 82.3% | 76/94 | 1 |
Lenz-Majewski_hyperostotic_dwarfism.yaml |
80.9% | 86.5% | 110/136 | |
Chromosome_18q_Deletion_Syndrome.yaml |
80.9% | 83.8% | 89/110 | |
COXFA4-Related_COX_Deficiency.yaml |
81.0% | 83.2% | 34/42 | |
Multiple_Mitochondrial_Dysfunctions_Syndrome_9B.yaml |
81.0% | 81.9% | 204/252 | |
HFM1-related_gametogenic_failure.yaml |
81.0% | 83.7% | 47/58 | |
Myocardial_Infarction.yaml |
81.1% | 85.4% | 77/95 | |
Peeling_Skin_Syndrome.yaml |
81.1% | 83.4% | 107/132 | |
Myhre_Syndrome.yaml |
81.1% | 83.1% | 137/169 | 1 |
Centronuclear_Myopathy.yaml |
81.2% | 84.1% | 138/170 | |
Orofaciodigital_Syndrome_Type_I.yaml |
81.2% | 83.4% | 108/133 | |
Glaucoma.yaml |
81.2% | 83.2% | 78/96 | 1 |
Multiple_Epiphyseal_Dysplasia_Al-Gazali_Type.yaml |
81.2% | 84.0% | 39/48 | |
Polymyositis.yaml |
81.2% | 83.9% | 78/96 | 1 |
SCO2-Related_Fatal_Infantile_Cardioencephalomyopathy.yaml |
81.2% | 85.1% | 26/32 | |
Branchiooculofacial_Syndrome.yaml |
81.3% | 83.4% | 113/139 | |
Melanoma_in_Congenital_Melanocytic_Nevus.yaml |
81.3% | 81.5% | 113/139 | 2 |
Wiedemann-Steiner_Syndrome.yaml |
81.3% | 83.9% | 100/123 | |
Ebola_Virus_Disease_EVD.yaml |
81.3% | 80.4% | 135/166 | 2 |
Focal_Dermal_Hypoplasia.yaml |
81.3% | 83.9% | 122/150 | |
Postpartum_Depression.yaml |
81.3% | 83.6% | 109/134 | |
Human_African_Trypanosomiasis.yaml |
81.4% | 80.6% | 48/59 | |
Lyme_Disease.yaml |
81.4% | 82.9% | 166/204 | |
Reelin_Pathway_Lissencephaly.yaml |
81.4% | 83.7% | 83/102 | 1 |
Scurvy.yaml |
81.4% | 81.5% | 35/43 | 1 |
VPS4A-Related_Neurodevelopmental_Syndrome.yaml |
81.4% | 84.6% | 175/215 | |
VAMP2-Related_Disorder.yaml |
81.4% | 84.6% | 57/70 | |
MHC_Class_II_Deficiency.yaml |
81.4% | 83.5% | 180/221 | |
CRX_Related_Retinopathy.yaml |
81.5% | 83.9% | 66/81 | |
Hand_Foot_and_Mouth_Disease.yaml |
81.5% | 88.0% | 172/211 | |
Gout.yaml |
81.5% | 83.5% | 106/130 | |
Classic_Familial_Adenomatous_Polyposis.yaml |
81.6% | 88.1% | 208/255 | |
COA8-Related_COX_Deficiency.yaml |
81.6% | 83.8% | 62/76 | |
Hereditary_von_Willebrand_Disease.yaml |
81.6% | 85.8% | 31/38 | |
Kearns-Sayre_Syndrome.yaml |
81.6% | 83.5% | 155/190 | |
Hereditary_Elliptocytosis.yaml |
81.6% | 83.0% | 164/201 | |
CPT1C-Related_Hereditary_Spastic_Paraplegia.yaml |
81.6% | 85.7% | 40/49 | |
Castleman_Disease.yaml |
81.6% | 84.8% | 80/98 | 1 |
KRT85_Ectodermal_Dysplasia.yaml |
81.6% | 84.4% | 40/49 | |
Tay-Sachs_Disease_AB_Variant.yaml |
81.7% | 85.6% | 49/60 | |
Dystrophic_Epidermolysis_Bullosa.yaml |
81.7% | 82.8% | 214/262 | |
Bethlem_Myopathy.yaml |
81.7% | 82.9% | 272/333 | |
Peripartum_Cardiomyopathy.yaml |
81.7% | 85.1% | 67/82 | |
Alagille_syndrome.yaml |
81.7% | 83.7% | 152/186 | |
Aland_Island_Eye_Disease.yaml |
81.7% | 83.8% | 76/93 | |
Idiopathic_Pulmonary_Fibrosis.yaml |
81.8% | 85.1% | 130/159 | |
Gorlin_Syndrome.yaml |
81.8% | 82.8% | 278/340 | 1 |
COX10-Related_COX_Deficiency.yaml |
81.8% | 85.4% | 27/33 | |
COX14-Related_COX_Deficiency.yaml |
81.8% | 84.4% | 27/33 | |
EBV_Associated_Gastric_Cancer.yaml |
81.8% | 84.1% | 81/99 | |
Focal_Articular_Cartilage_Defect_of_the_Knee.yaml |
81.8% | 85.2% | 54/66 | |
UNC13A_NDD_with_Seizures_and_Movement_Disorder.yaml |
81.8% | 82.8% | 108/132 | 2 |
Angelman_Syndrome.yaml |
81.9% | 83.3% | 397/485 | |
BRAF_V600E_Mutant_Colorectal_Cancer.yaml |
81.9% | 81.4% | 158/193 | 1 |
Medullary_Thyroid_Carcinoma.yaml |
81.9% | 84.9% | 77/94 | 1 |
Inclusion_Body_Myopathy_with_Paget_Disease_of_Bone_and_Frontotemporal_Dementia.yaml |
82.0% | 83.8% | 168/205 | |
Central_Precocious_Puberty.yaml |
82.0% | 84.5% | 41/50 | |
Combined_Saposin_Deficiency.yaml |
82.0% | 85.0% | 41/50 | |
Krabbe_Disease_Due_To_Saposin_A_Deficiency.yaml |
82.0% | 86.4% | 41/50 | |
Testicular_Seminoma.yaml |
82.0% | 85.0% | 82/100 | |
Adenoid_Cystic_Carcinoma.yaml |
82.0% | 84.5% | 137/167 | |
Infantile_Spasms.yaml |
82.0% | 83.0% | 137/167 | 1 |
Global_Developmental_Delay_Progressive_Ataxia_and_Elevated_Glutamine.yaml |
82.1% | 83.9% | 64/78 | |
Asbestosis.yaml |
82.1% | 85.5% | 87/106 | |
Giant_Cell_Hepatitis_With_Autoimmune_Hemolytic_Anemia.yaml |
82.1% | 84.7% | 87/106 | |
EDN3_EDNRB_Waardenburg_Shah.yaml |
82.1% | 84.9% | 55/67 | |
Saethre-Chotzen_Syndrome.yaml |
82.1% | 85.3% | 55/67 | |
Ullrich_Congenital_Muscular_Dystrophy.yaml |
82.1% | 83.6% | 220/268 | |
Wiskott_Aldrich_Syndrome.yaml |
82.1% | 84.3% | 165/201 | |
Leber_Congenital_Amaurosis_10.yaml |
82.1% | 86.2% | 69/84 | |
Schwannomatosis.yaml |
82.2% | 84.2% | 83/101 | 1 |
Chemotherapy_Induced_Diarrhea.yaml |
82.2% | 83.1% | 157/191 | |
Primary_Carnitine_Deficiency.yaml |
82.2% | 83.6% | 157/191 | |
Glioma.yaml |
82.2% | 85.4% | 97/118 | |
COX5A-Related_COX_Deficiency.yaml |
82.2% | 84.7% | 37/45 | |
Tatton-Brown-Rahman_overgrowth_syndrome.yaml |
82.2% | 84.7% | 37/45 | |
Sarcoidosis.yaml |
82.2% | 83.3% | 324/394 | 2 |
CLOVES_Syndrome.yaml |
82.3% | 83.9% | 190/231 | |
Siderius_Type_X-Linked_Intellectual_Disability.yaml |
82.3% | 83.5% | 218/265 | |
Moyamoya_Disease.yaml |
82.3% | 86.0% | 65/79 | 1 |
Tuberous_Sclerosis_Complex.yaml |
82.3% | 83.9% | 377/458 | |
Ovarian_High-Grade_Serous_Carcinoma.yaml |
82.3% | 83.2% | 135/164 | 2 |
Short-Rib_Polydactyly_Syndrome.yaml |
82.4% | 83.8% | 112/136 | |
Inborn_Disorder_of_Cobalamin_Metabolism_and_Transport.yaml |
82.4% | 85.5% | 89/108 | |
Van_Buchem_Disease.yaml |
82.4% | 83.1% | 89/108 | |
Joubert_syndrome.yaml |
82.4% | 83.6% | 530/643 | |
NF1_Microdeletion_Syndrome.yaml |
82.4% | 84.8% | 61/74 | |
Pelizaeus_Merzbacher_Disease.yaml |
82.4% | 84.8% | 183/222 | |
Brachyolmia.yaml |
82.5% | 84.1% | 188/228 | |
Alzheimer_Disease.yaml |
82.5% | 79.9% | 409/496 | 6 |
Solitary_Fibrous_Tumor.yaml |
82.5% | 85.2% | 66/80 | |
DECR_Deficiency.yaml |
82.6% | 84.9% | 123/149 | |
DOORS_Syndrome.yaml |
82.6% | 84.3% | 90/109 | |
KBG_Syndrome.yaml |
82.6% | 85.0% | 128/155 | |
Neuromyelitis_Optica.yaml |
82.6% | 82.0% | 128/155 | 5 |
Fallopian_Tube_Cancer.yaml |
82.6% | 85.8% | 57/69 | |
Tay-Sachs_Disease.yaml |
82.6% | 84.2% | 200/242 | |
Alveolar_Capillary_Dysplasia_with_Misalignment_of_Pulmonary_Veins.yaml |
82.7% | 84.2% | 81/98 | |
IREB2-Related_Neurodegeneration.yaml |
82.7% | 83.4% | 248/300 | 1 |
Heart_Defect_Tongue_Hamartoma_Polysyndactyly_Syndrome.yaml |
82.7% | 85.5% | 43/52 | |
Mucolipidosis_Type_IV.yaml |
82.7% | 86.0% | 43/52 | |
YWHAG_Syndrome.yaml |
82.7% | 84.5% | 134/162 | |
Smith-Magenis_Syndrome.yaml |
82.7% | 85.3% | 139/168 | |
HROB-related_gametogenic_failure.yaml |
82.8% | 84.5% | 72/87 | |
Retinal_Arterial_Tortuosity.yaml |
82.8% | 84.2% | 72/87 | |
Peroxisome_Biogenesis_Disorder.yaml |
82.8% | 82.6% | 226/273 | 1 |
Advanced_Sleep_Phase_Syndrome.yaml |
82.8% | 83.5% | 231/279 | 2 |
Severe_Combined_Immunodeficiency.yaml |
82.8% | 85.2% | 130/157 | |
Long_QT_Syndrome.yaml |
82.9% | 84.0% | 232/280 | 4 |
Papillary_Thyroid_Carcinoma.yaml |
82.9% | 85.4% | 58/70 | |
Leukoencephalopathy_With_Vanishing_White_Matter.yaml |
82.9% | 85.6% | 92/111 | |
Geleophysic_Dysplasia.yaml |
82.9% | 84.7% | 175/211 | |
Noise_Induced_Hearing_Loss.yaml |
82.9% | 84.6% | 107/129 | |
CYCS-Related_Thrombocytopenia.yaml |
83.0% | 85.8% | 39/47 | |
capillary_leak_syndrome.yaml |
83.0% | 85.9% | 39/47 | |
Fibrous_Dysplasia.yaml |
83.0% | 84.9% | 200/241 | |
Dacryocystitis-Osteopoikilosis_Syndrome.yaml |
83.0% | 85.7% | 83/100 | |
Williams_Syndrome.yaml |
83.0% | 85.7% | 137/165 | |
Hypophosphatasia.yaml |
83.1% | 85.5% | 152/183 | |
Hereditary_Breast_and_Ovarian_Cancer_Syndrome.yaml |
83.1% | 83.2% | 108/130 | 1 |
Hypochondroplasia.yaml |
83.1% | 84.9% | 162/195 | |
Holt-Oram_Syndrome.yaml |
83.1% | 84.7% | 118/142 | 2 |
Charcot-Marie-Tooth_Disease_X-linked_Recessive_4.yaml |
83.1% | 85.1% | 123/148 | |
DYRK1A_Syndrome.yaml |
83.1% | 85.2% | 133/160 | |
Cornelia_de_Lange_Syndrome.yaml |
83.1% | 84.7% | 202/243 | |
Myotonic_Dystrophy_Type_1.yaml |
83.1% | 85.0% | 138/166 | 1 |
Testicular_Sex_Cord_Stromal_Neoplasm.yaml |
83.1% | 85.8% | 69/83 | 1 |
Hypermobile_Ehlers-Danlos_Syndrome.yaml |
83.2% | 83.3% | 153/184 | 2 |
Andersen-Tawil_Syndrome.yaml |
83.2% | 84.5% | 232/279 | |
Elsahy-Waters_Syndrome.yaml |
83.2% | 86.3% | 79/95 | |
Glucose-6-Phosphate_Dehydrogenase_G6PD_Deficiency.yaml |
83.2% | 84.8% | 129/155 | |
Congenital_Dyserythropoietic_Anemia.yaml |
83.2% | 85.2% | 164/197 | |
Avoidant_Restrictive_Food_Intake_Disorder.yaml |
83.3% | 84.8% | 75/90 | |
Dyskeratosis_Congenita.yaml |
83.3% | 85.4% | 265/318 | |
FASTKD5-Related_COX_Deficiency.yaml |
83.3% | 85.4% | 35/42 | |
Familial_Chylomicronemia_Syndrome.yaml |
83.3% | 85.3% | 85/102 | |
Kniest_Dysplasia.yaml |
83.3% | 84.4% | 135/162 | 1 |
Paroxysmal_Dyskinesia.yaml |
83.3% | 84.8% | 280/336 | 2 |
Pentanucleotide_Repeat_Familial_Adult_Myoclonus_Epilepsy.yaml |
83.3% | 84.1% | 165/198 | 1 |
Primary_Tonsillar_Lymphoma.yaml |
83.3% | 83.6% | 140/168 | 1 |
Renal_Agenesis.yaml |
83.3% | 85.6% | 70/84 | |
SURF1-Related_Leigh_Syndrome.yaml |
83.3% | 85.5% | 70/84 | 2 |
THUMPD1-Related_Neurodevelopmental_Disorder.yaml |
83.3% | 85.4% | 55/66 | |
VEXAS_Syndrome.yaml |
83.3% | 85.6% | 100/120 | |
Guanidinoacetate_Methyltransferase_Deficiency.yaml |
83.4% | 84.6% | 181/217 | |
Oculodentodigital_Dysplasia.yaml |
83.4% | 85.5% | 151/181 | |
Microscopic_Polyangiitis.yaml |
83.4% | 85.7% | 136/163 | |
CTCF-related_Neurodevelopmental_Disorder.yaml |
83.4% | 86.0% | 131/157 | |
Metatropic_Dysplasia.yaml |
83.5% | 86.1% | 111/133 | |
Rheumatoid_Arthritis.yaml |
83.5% | 83.6% | 333/399 | 4 |
TUBB2A_TUBB2B-related_Cortical_Malformation.yaml |
83.5% | 85.4% | 91/109 | 2 |
Pantothenate_Kinase-Associated_Neurodegeneration.yaml |
83.5% | 85.3% | 86/103 | |
Rett_Syndrome.yaml |
83.5% | 85.1% | 172/206 | |
TUBB3-related_Tubulinopathy.yaml |
83.5% | 85.9% | 81/97 | 2 |
Monkeypox.yaml |
83.5% | 83.2% | 152/182 | 2 |
Scapuloperoneal_Spinal_Muscular_Atrophy.yaml |
83.5% | 86.2% | 66/79 | |
Hartsfield_Syndrome.yaml |
83.6% | 85.4% | 61/73 | |
PRR12-Related_Neuroocular_Syndrome.yaml |
83.6% | 85.4% | 234/280 | |
Taurodontism.yaml |
83.6% | 89.3% | 117/140 | |
Weaver_Syndrome.yaml |
83.6% | 85.3% | 107/128 | 1 |
Von_Hippel-Lindau_Disease.yaml |
83.6% | 84.4% | 97/116 | |
Hydrolethalus_Syndrome_2.yaml |
83.6% | 86.0% | 46/55 | |
Malan_Syndrome.yaml |
83.6% | 86.0% | 92/110 | |
Subacute_Inflammatory_Demyelinating_Polyneuropathy.yaml |
83.6% | 85.8% | 46/55 | 1 |
Stromme_Syndrome.yaml |
83.7% | 84.9% | 174/208 | |
SNIP1-Related_Neurodevelopmental_Disorder.yaml |
83.7% | 85.1% | 405/484 | |
NRAS_Mutant_Melanoma.yaml |
83.7% | 85.8% | 77/92 | 1 |
Hereditary_Angioedema.yaml |
83.7% | 84.6% | 216/258 | |
Pyruvate_Kinase_Deficiency.yaml |
83.7% | 85.8% | 72/86 | |
Asthma.yaml |
83.8% | 83.2% | 356/425 | 4 |
COX6B1-Related_COX_Deficiency.yaml |
83.8% | 87.2% | 31/37 | |
PTEN_Hamartoma_Tumor_Syndrome.yaml |
83.8% | 85.4% | 124/148 | |
Bladder_Urothelial_Carcinoma.yaml |
83.8% | 86.6% | 83/99 | |
DEPDC5-Related_Epilepsy.yaml |
83.9% | 85.5% | 104/124 | 1 |
Holoprosencephaly_12_With_or_Without_Pancreatic_Agenesis.yaml |
83.9% | 84.9% | 156/186 | 1 |
Thanatophoric_Dysplasia_Type_2.yaml |
83.9% | 84.5% | 177/211 | |
Hereditary_Arterial_and_Articular_Multiple_Calcification_Syndrome.yaml |
83.9% | 86.5% | 73/87 | 1 |
Infantile_Hypercalcemia.yaml |
83.9% | 88.2% | 219/261 | |
Dermatofibrosarcoma_Protuberans.yaml |
83.9% | 84.7% | 47/56 | 2 |
Sjogren-Larsson_Syndrome.yaml |
84.0% | 85.8% | 136/162 | |
Madras_Motor_Neuron_Disease.yaml |
84.0% | 87.1% | 42/50 | |
SOX10_Neurocristopathy_Spectrum.yaml |
84.0% | 86.7% | 63/75 | |
Skin_Fragility_Woolly_Hair_Syndrome.yaml |
84.0% | 87.2% | 42/50 | |
Boucher-Neuhauser_Syndrome.yaml |
84.0% | 84.7% | 142/169 | 1 |
Autosomal_Dominant_Sensory_Ataxia_1.yaml |
84.1% | 85.2% | 195/232 | |
CLCN2-Related_Leukoencephalopathy.yaml |
84.1% | 86.2% | 248/295 | |
Bejel.yaml |
84.1% | 86.0% | 74/88 | |
Bulimia_Nervosa.yaml |
84.1% | 85.9% | 74/88 | |
ZTTK_syndrome.yaml |
84.1% | 86.6% | 37/44 | |
Fibrodysplasia_Ossificans_Progressiva.yaml |
84.1% | 88.2% | 122/145 | |
Mitochondrial_Complex_II_Deficiency_Nuclear_Type_1.yaml |
84.1% | 85.8% | 69/82 | 1 |
Spondyloepimetaphyseal_Dysplasia_Strudwick_Type.yaml |
84.1% | 85.3% | 138/164 | 1 |
Temple-Baraitser_Syndrome.yaml |
84.1% | 86.7% | 138/164 | |
Systemic_Sclerosis.yaml |
84.2% | 87.4% | 85/101 | |
Hemophilia_A.yaml |
84.2% | 85.2% | 101/120 | |
Tooth_and_Nail_Syndrome.yaml |
84.2% | 85.3% | 64/76 | 1 |
Kleefstra_Syndrome.yaml |
84.3% | 86.8% | 91/108 | |
NR5A1_Related_Sex_Development_Disorder.yaml |
84.3% | 86.6% | 91/108 | |
Paranasal_Sinus_Squamous_Cell_Carcinoma.yaml |
84.3% | 86.6% | 75/89 | |
Hypereosinophilic_Syndrome.yaml |
84.3% | 87.1% | 129/153 | |
Sinoatrial_Block.yaml |
84.3% | 87.6% | 43/51 | |
X-linked_Syndromic_Intellectual_Disability_Turner_Type.yaml |
84.3% | 86.8% | 43/51 | |
Neurofibromatosis_Type_1.yaml |
84.3% | 86.3% | 156/185 | |
UNC13A_Congenital_NDD_with_Epilepsy.yaml |
84.4% | 84.6% | 151/179 | 2 |
Mowat-Wilson_syndrome.yaml |
84.4% | 86.8% | 65/77 | |
Small_Intestinal_Bacterial_Overgrowth.yaml |
84.4% | 86.7% | 65/77 | |
Nestor-Guillermo_progeria_syndrome.yaml |
84.4% | 86.7% | 38/45 | |
Triphalangeal_Thumb_Polysyndactyly.yaml |
84.4% | 86.0% | 38/45 | |
Congenital_Adrenal_Hyperplasia.yaml |
84.5% | 86.6% | 125/148 | |
Labyrinthitis.yaml |
84.5% | 86.9% | 185/219 | 1 |
Niemann_Pick_Disease_Type_C.yaml |
84.5% | 86.0% | 207/245 | |
2q37_Microdeletion_Syndrome.yaml |
84.5% | 85.7% | 120/142 | |
Rocky_Mountain_Spotted_Fever.yaml |
84.5% | 85.3% | 262/310 | |
Rubinstein-Taybi_Syndrome.yaml |
84.5% | 86.2% | 131/155 | |
Ovarian_Mucinous_Carcinoma.yaml |
84.5% | 87.7% | 71/84 | |
Rhabdoid_Tumor.yaml |
84.5% | 87.3% | 71/84 | |
ER_Positive_Breast_Cancer.yaml |
84.5% | 86.6% | 82/97 | 1 |
Hashimotos_Thyroiditis.yaml |
84.6% | 86.8% | 126/149 | |
Fanconi_Anemia.yaml |
84.6% | 86.0% | 932/1102 | |
COX6A2-Related_COX_Deficiency.yaml |
84.6% | 87.3% | 33/39 | |
Congenital_Hypofibrinogenemia.yaml |
84.6% | 87.0% | 44/52 | |
Juvenile_Myelomonocytic_Leukemia.yaml |
84.6% | 85.6% | 99/117 | |
Lipoid_Proteinosis.yaml |
84.6% | 86.5% | 110/130 | |
Proteus_syndrome.yaml |
84.6% | 85.9% | 187/221 | |
Urticaria.yaml |
84.6% | 92.3% | 11/13 | |
GLUT1_Deficiency_Syndrome.yaml |
84.7% | 85.0% | 116/137 | 3 |
Mixed_Neuronal-Glial_Tumor.yaml |
84.7% | 87.3% | 72/85 | |
Pica.yaml |
84.7% | 86.1% | 72/85 | |
Congenital_Sialidosis_Type_2.yaml |
84.8% | 87.5% | 39/46 | |
EAST_Syndrome.yaml |
84.8% | 86.4% | 78/92 | 1 |
Leber_Congenital_Amaurosis_with_Early-Onset_Deafness.yaml |
84.8% | 87.9% | 39/46 | |
Synovial_Sarcoma.yaml |
84.8% | 85.3% | 78/92 | 1 |
USP8-related_pituitary_adenoma_4.yaml |
84.8% | 88.3% | 78/92 | |
MED13_Syndrome.yaml |
84.8% | 85.3% | 290/342 | 1 |
Metastatic_Colorectal_Cancer.yaml |
84.8% | 86.1% | 67/79 | |
Craniofacial_Microsomia.yaml |
84.8% | 86.5% | 218/257 | |
Metastatic_Pancreatic_Adenocarcinoma.yaml |
84.8% | 84.9% | 123/145 | |
CINCA_Syndrome.yaml |
84.8% | 86.6% | 263/310 | 2 |
Cogan_Syndrome.yaml |
84.8% | 85.9% | 168/198 | |
Omodysplasia.yaml |
84.8% | 85.9% | 168/198 | |
Lymphangioleiomyomatosis.yaml |
84.9% | 86.8% | 90/106 | |
Primrose_Syndrome.yaml |
84.9% | 86.7% | 152/179 | |
Kilquist_Syndrome.yaml |
84.9% | 85.3% | 107/126 | |
Rosai-Dorfman_Disease.yaml |
85.0% | 87.5% | 113/133 | |
GPR101-related_pituitary_adenoma_2.yaml |
85.0% | 88.1% | 85/100 | |
Mediator_Complex_Neurodevelopmental_Disorder.yaml |
85.0% | 85.5% | 289/340 | 1 |
G6PC3_Deficiency.yaml |
85.0% | 85.5% | 182/214 | 3 |
Autosomal_Dominant_Progressive_External_Ophthalmoplegia.yaml |
85.1% | 86.1% | 313/368 | |
Embryonal_Rhabdomyosarcoma.yaml |
85.1% | 88.0% | 57/67 | |
Wissler_syndrome.yaml |
85.1% | 87.4% | 160/188 | |
POLR-Related_Leukodystrophy.yaml |
85.1% | 86.5% | 263/309 | |
Ritscher-Schinzel_Syndrome.yaml |
85.1% | 87.2% | 143/168 | |
FLVCR1-Related_Retinopathy.yaml |
85.1% | 88.0% | 63/74 | |
Malignant_Atrophic_Papulosis.yaml |
85.1% | 86.8% | 63/74 | |
Epilepsy.yaml |
85.2% | 86.6% | 281/330 | |
Behcets_Disease.yaml |
85.2% | 87.7% | 109/128 | |
Prader-Willi_Syndrome.yaml |
85.2% | 86.2% | 178/209 | |
Basal_Cell_Carcinoma.yaml |
85.2% | 86.3% | 138/162 | |
HAO1-Related_Glycolate_Oxidase_Deficiency.yaml |
85.2% | 89.0% | 23/27 | |
Peutz_Jeghers_polyp.yaml |
85.2% | 88.2% | 138/162 | |
Tall_Stature-Intellectual_Disability-Renal_Anomalies_Syndrome.yaml |
85.2% | 87.1% | 69/81 | |
erythromelalgia.yaml |
85.2% | 87.1% | 46/54 | |
CACNA1E-Related_Developmental_and_Epileptic_Encephalopathy.yaml |
85.2% | 86.9% | 98/115 | |
Celiac_Disease.yaml |
85.2% | 86.9% | 150/176 | |
Postural_Orthostatic_Tachycardia_Syndrome.yaml |
85.3% | 87.5% | 133/156 | |
Nevus_of_Ota.yaml |
85.3% | 87.8% | 58/68 | |
PET117-Related_COX_Deficiency.yaml |
85.3% | 87.8% | 29/34 | |
Pneumocystis_Pneumonia.yaml |
85.3% | 89.2% | 29/34 | |
SLC26A1-Related_Oxalate_Transporter_Deficiency.yaml |
85.3% | 89.0% | 29/34 | |
FLT3_Mutant_AML.yaml |
85.3% | 87.5% | 93/109 | |
Mixed_Phenotype_Acute_Leukemia.yaml |
85.3% | 86.8% | 314/368 | |
Auriculocondylar_Syndrome.yaml |
85.3% | 85.6% | 128/150 | 1 |
SYT1_Baker-Gordon_Syndrome.yaml |
85.3% | 87.8% | 64/75 | |
Ulnar-Mammary_Syndrome.yaml |
85.3% | 86.4% | 192/225 | |
Enhanced_S-Cone_Syndrome.yaml |
85.4% | 89.5% | 70/82 | |
RCBTB1-Related_Retinopathy.yaml |
85.4% | 88.3% | 70/82 | |
Triglyceride_Storage_Disease_Type_2.yaml |
85.4% | 90.2% | 35/41 | |
Ehlers-Danlos_Syndrome_COL5A1-related.yaml |
85.4% | 86.4% | 111/130 | |
Ameloblastoma.yaml |
85.4% | 87.7% | 76/89 | |
Spondylocarpotarsal_Synostosis_Syndrome.yaml |
85.4% | 87.5% | 129/151 | |
X-Linked_Hypophosphatemia.yaml |
85.4% | 88.0% | 88/103 | |
Osteogenesis_Imperfecta_Type_VII.yaml |
85.5% | 86.1% | 94/110 | |
Classic_Hodgkin_Lymphoma.yaml |
85.5% | 87.9% | 100/117 | |
Kanzaki_Disease.yaml |
85.5% | 88.0% | 53/62 | |
Pearson_Syndrome.yaml |
85.5% | 87.4% | 53/62 | |
Spinal_Muscular_Atrophy_Progressive_Myoclonic_Epilepsy.yaml |
85.5% | 90.8% | 53/62 | |
Spasticity-Ataxia-Gait_Anomalies_Syndrome.yaml |
85.5% | 88.4% | 59/69 | |
Leigh_Syndrome.yaml |
85.5% | 87.8% | 130/152 | |
Chagas_Disease.yaml |
85.5% | 86.4% | 136/159 | 1 |
Hypoplasminogenemia.yaml |
85.6% | 86.8% | 77/90 | 1 |
ADCA-DN.yaml |
85.6% | 86.2% | 261/305 | |
Aromatic_L_Amino_Acid_Decarboxylase_Deficiency.yaml |
85.6% | 86.4% | 261/305 | |
Clouston_Syndrome.yaml |
85.6% | 87.0% | 89/104 | |
Viral_Hemorrhagic_Fever.yaml |
85.6% | 87.7% | 101/118 | |
15q11q13_Microduplication_Syndrome.yaml |
85.6% | 86.9% | 208/243 | |
Ehlers-Danlos_Syndrome.yaml |
85.6% | 84.9% | 214/250 | 1 |
Mandibulofacial_Dysostosis_with_Microcephaly.yaml |
85.6% | 86.9% | 113/132 | |
Ogden_syndrome.yaml |
85.6% | 87.2% | 125/146 | |
Kawasaki_Disease.yaml |
85.6% | 86.6% | 304/355 | 1 |
Abdominal_Aortic_Aneurysm.yaml |
85.7% | 88.6% | 54/63 | |
Familial_Hyperaldosteronism_Type_I.yaml |
85.7% | 86.2% | 120/140 | |
Methanol_Poisoning.yaml |
85.7% | 87.8% | 126/147 | |
Pemphigus_Erythematosus.yaml |
85.7% | 87.6% | 42/49 | |
Periventricular_Nodular_Heterotopia.yaml |
85.7% | 87.6% | 144/168 | 1 |
RAB33B-Related_Smith-McCort_Dysplasia_2.yaml |
85.7% | 88.0% | 54/63 | |
Renal_Cell_Carcinoma.yaml |
85.7% | 85.4% | 48/56 | 2 |
SLC26A6-Related_Hyperoxaluria_and_Nephrolithiasis.yaml |
85.7% | 88.7% | 36/42 | |
aceruloplasminemia.yaml |
85.7% | 87.0% | 90/105 | |
Marfan_Syndrome.yaml |
85.8% | 85.4% | 235/274 | 2 |
RET_Rearranged_NSCLC.yaml |
85.8% | 85.3% | 163/190 | 1 |
EML1_Ribbon_Heterotopia.yaml |
85.8% | 87.3% | 103/120 | 2 |
Thymic_Neuroendocrine_Carcinoma.yaml |
85.8% | 87.0% | 285/332 | |
Esophageal_Carcinoma.yaml |
85.8% | 87.4% | 91/106 | |
Allan-Herndon-Dudley_Syndrome.yaml |
85.9% | 86.4% | 261/304 | |
Opsismodysplasia.yaml |
85.9% | 87.3% | 170/198 | |
Cardiomyopathy-Hypotonia-Lactic_Acidosis_Syndrome.yaml |
85.9% | 86.7% | 164/191 | 1 |
Intellectual_Disability_Anterior_Maxillary_Protrusion_and_Strabismus.yaml |
85.9% | 87.9% | 146/170 | |
GNPTG-Mucolipidosis.yaml |
85.9% | 89.5% | 67/78 | |
Glutaryl-CoA_Dehydrogenase_Deficiency.yaml |
85.9% | 89.2% | 189/220 | |
Aicardi_Goutieres_Syndrome.yaml |
85.9% | 86.6% | 250/291 | |
Reversible_Infantile_Cytochrome_c_Oxidase_Deficiency.yaml |
85.9% | 87.6% | 61/71 | |
X-Linked_Infantile_Spinal_Muscular_Atrophy.yaml |
85.9% | 87.8% | 61/71 | |
Chronic_Mucocutaneous_Candidiasis.yaml |
85.9% | 87.1% | 336/391 | |
Thymic_Carcinoma.yaml |
86.0% | 88.4% | 104/121 | |
Central_Serous_Chorioretinopathy.yaml |
86.0% | 88.4% | 98/114 | |
Dementia_with_Lewy_Bodies.yaml |
86.0% | 88.4% | 43/50 | |
Diastrophic_Dysplasia.yaml |
86.0% | 87.3% | 172/200 | |
Gastric_Adenocarcinoma.yaml |
86.0% | 86.8% | 314/365 | |
Klippel-Feil_Syndrome.yaml |
86.0% | 89.6% | 37/43 | |
Usher_Syndrome.yaml |
86.0% | 87.9% | 111/129 | |
Severe_Neonatal-Onset_Encephalopathy_With_Microcephaly.yaml |
86.1% | 86.5% | 401/466 | |
Chromosome_2q32-q33_Deletion_Syndrome.yaml |
86.1% | 87.8% | 173/201 | |
Nephronophthisis.yaml |
86.1% | 86.3% | 167/194 | 1 |
MSTO1-Related_Mitochondrial_Myopathy.yaml |
86.1% | 87.1% | 266/309 | 2 |
Parkinsons_Disease.yaml |
86.1% | 86.4% | 359/417 | 2 |
Complex_Hereditary_Spastic_Paraplegia.yaml |
86.1% | 87.4% | 124/144 | 1 |
Familial_Thoracic_Aortic_Aneurysm_and_Aortic_Dissection.yaml |
86.1% | 87.6% | 124/144 | 1 |
Keratoconus.yaml |
86.1% | 86.9% | 186/216 | 1 |
Urea_Cycle_Disorder.yaml |
86.1% | 86.6% | 217/252 | 1 |
Cori_Forbes_Disease.yaml |
86.1% | 87.7% | 118/137 | |
Choroideremia-Deafness-Obesity_Syndrome.yaml |
86.1% | 87.8% | 87/101 | |
Vascular_Ehlers-Danlos_Syndrome.yaml |
86.1% | 87.4% | 87/101 | |
Floating-Harbor_syndrome.yaml |
86.2% | 88.7% | 56/65 | |
Alcoholic_Liver_Disease.yaml |
86.2% | 85.4% | 187/217 | 2 |
Familial_Nonmedullary_Thyroid_Carcinoma.yaml |
86.2% | 86.9% | 331/384 | |
COX15-Related_COX_Deficiency.yaml |
86.2% | 89.9% | 25/29 | |
PIK3CA_Mutant_Breast_Cancer.yaml |
86.2% | 90.2% | 50/58 | |
RARB-related_syndromic_microphthalmia.yaml |
86.2% | 88.1% | 169/196 | |
Huntington_Disease-like_2.yaml |
86.2% | 87.0% | 69/80 | |
KRT1_Keratinopathies.yaml |
86.2% | 87.7% | 69/80 | |
COX16-Related_COX_Deficiency.yaml |
86.3% | 88.4% | 44/51 | |
Central_Core_Myopathy.yaml |
86.3% | 87.9% | 176/204 | |
LRBA_Deficiency.yaml |
86.3% | 88.8% | 88/102 | |
Osteogenesis_Imperfecta_Type_V.yaml |
86.3% | 88.6% | 88/102 | |
Wieacker_Wolff_Syndrome.yaml |
86.3% | 87.3% | 145/168 | |
Intracranial_Berry_Aneurysm.yaml |
86.3% | 89.4% | 82/95 | |
Canavan_Disease.yaml |
86.3% | 87.4% | 183/212 | |
Fragile_X_Syndrome.yaml |
86.4% | 87.9% | 190/220 | |
Panuveitis.yaml |
86.4% | 87.6% | 76/88 | 1 |
Thyroid_Follicular_Carcinoma.yaml |
86.4% | 89.4% | 76/88 | |
Charcot-Marie-Tooth_Disease_Type_2.yaml |
86.4% | 88.3% | 165/191 | |
Odonto-Onycho-Dermal_Dysplasia.yaml |
86.4% | 88.2% | 127/147 | |
Jet_Lag.yaml |
86.4% | 88.0% | 70/81 | |
Paratyphoid_Fever.yaml |
86.4% | 88.4% | 70/81 | |
Myasthenia_Gravis.yaml |
86.4% | 88.0% | 191/221 | |
Cholesteryl_Ester_Storage_Disease.yaml |
86.4% | 89.1% | 51/59 | |
Ovarian_Endometrioid_Carcinoma.yaml |
86.5% | 88.2% | 83/96 | |
Coronary_Artery_Congenital_Malformation.yaml |
86.5% | 89.1% | 96/111 | |
Dental_Caries.yaml |
86.5% | 89.1% | 64/74 | |
Hemophilia_B.yaml |
86.5% | 90.4% | 32/37 | |
GUCY2D-Related_Retinopathy.yaml |
86.5% | 89.4% | 77/89 | |
Succinic_Semialdehyde_Dehydrogenase_Deficiency.yaml |
86.5% | 90.9% | 193/223 | |
Oculocerebrodental_Syndrome.yaml |
86.6% | 89.2% | 58/67 | |
Multicentric_Castleman_Disease.yaml |
86.6% | 88.0% | 84/97 | |
Familial_Congenital_Mirror_Movements.yaml |
86.6% | 88.4% | 97/112 | |
COX8A-Related_COX_Deficiency.yaml |
86.7% | 89.9% | 26/30 | |
CTLA4_Haploinsufficiency.yaml |
86.7% | 88.4% | 65/75 | |
Dyslexia.yaml |
86.7% | 89.3% | 52/60 | |
Hereditary_Hyperekplexia.yaml |
86.7% | 88.1% | 156/180 | |
Long-Chain_3-Hydroxyacyl-CoA_Dehydrogenase_Deficiency.yaml |
86.7% | 88.0% | 182/210 | |
Multisystem_Inflammatory_Syndrome_in_Children_MIS-C.yaml |
86.7% | 87.1% | 195/225 | 1 |
Onchocerciasis.yaml |
86.7% | 87.7% | 65/75 | |
Spinal_Muscular_Atrophy_with_Respiratory_Distress_Type_1.yaml |
86.7% | 88.8% | 78/90 | |
Hajdu-Cheney_Syndrome.yaml |
86.7% | 88.6% | 85/98 | |
IGF1_Deficiency.yaml |
86.7% | 88.6% | 72/83 | |
Alexander_Disease.yaml |
86.8% | 87.4% | 203/234 | |
Bartter_Syndrome.yaml |
86.8% | 87.4% | 262/302 | |
Heritable_Pulmonary_Arterial_Hypertension.yaml |
86.8% | 87.5% | 177/204 | 3 |
Neuronal_Ceroid_Lipofuscinosis_1.yaml |
86.8% | 89.4% | 59/68 | |
Atrial_Standstill.yaml |
86.8% | 88.1% | 164/189 | |
Congestive_Splenomegaly.yaml |
86.8% | 90.3% | 79/91 | |
Kummell_Disease.yaml |
86.8% | 87.9% | 112/129 | 1 |
Exstrophy-Epispadias_Complex.yaml |
86.8% | 91.0% | 99/114 | |
Paroxysmal_Familial_Ventricular_Fibrillation.yaml |
86.8% | 90.7% | 66/76 | |
Visceral_Heterotaxy.yaml |
86.8% | 90.2% | 66/76 | |
Green_Tobacco_Sickness.yaml |
86.9% | 88.1% | 119/137 | |
Short_QT_Syndrome.yaml |
86.9% | 88.4% | 119/137 | |
Esophageal_Adenocarcinoma.yaml |
86.9% | 89.9% | 106/122 | |
MALT_Lymphoma.yaml |
86.9% | 89.8% | 53/61 | |
Orofaciodigital_Syndrome_17.yaml |
86.9% | 89.6% | 53/61 | |
Tularemia.yaml |
86.9% | 89.2% | 53/61 | |
Weill-Marchesani_Syndrome.yaml |
86.9% | 88.3% | 159/183 | |
HCN1-Related_Developmental_and_Epileptic_Encephalopathy.yaml |
86.9% | 89.6% | 73/84 | |
Prostate_Adenocarcinoma.yaml |
86.9% | 88.9% | 73/84 | 1 |
Narcolepsy-Cataplexy_Syndrome.yaml |
87.0% | 88.5% | 80/92 | |
Dieulafoy_Lesion.yaml |
87.0% | 88.3% | 47/54 | |
Polycythemia_Vera.yaml |
87.0% | 88.4% | 141/162 | 1 |
Alstrom_Syndrome.yaml |
87.1% | 88.6% | 101/116 | 1 |
Cervical_Artery_Dissection.yaml |
87.1% | 89.7% | 54/62 | |
Multiple_Myeloma.yaml |
87.1% | 89.2% | 108/124 | 1 |
THOC2-Related_Intellectual_Disability.yaml |
87.1% | 87.7% | 237/272 | |
Rumination_Disorder.yaml |
87.1% | 88.3% | 61/70 | |
Auditory_Neuropathy.yaml |
87.2% | 88.2% | 95/109 | 1 |
Down_syndrome.yaml |
87.2% | 88.7% | 129/148 | |
Bryant-Li-Bhoj_Neurodevelopmental_Syndrome_2.yaml |
87.2% | 89.1% | 272/312 | |
Chromoblastomycosis.yaml |
87.2% | 88.2% | 34/39 | |
Primary_Triglyceride_Deposit_Cardiomyovasculopathy.yaml |
87.2% | 91.0% | 34/39 | |
SPTBN4-Related_Neurodevelopmental_Disorder.yaml |
87.2% | 88.8% | 286/328 | |
Dentici-Novelli_neurodevelopmental_syndrome.yaml |
87.2% | 89.2% | 75/86 | |
Acute_Motor_and_Sensory_Axonal_Neuropathy.yaml |
87.2% | 88.0% | 232/266 | |
Carney-Stratakis_Syndrome.yaml |
87.2% | 89.3% | 82/94 | |
Immunodeficiency_93_and_Hypertrophic_Cardiomyopathy.yaml |
87.2% | 88.5% | 164/188 | |
Otofacial_Neurodevelopmental_Syndrome.yaml |
87.3% | 89.2% | 178/204 | |
Fragile_X-Associated_Primary_Ovarian_Insufficiency.yaml |
87.3% | 88.8% | 137/157 | |
SLC6A1-Related_Disorder.yaml |
87.3% | 89.2% | 144/165 | 2 |
White-Sutton_Syndrome.yaml |
87.3% | 88.8% | 179/205 | |
Fibrosarcoma.yaml |
87.3% | 90.2% | 62/71 | |
Koolen_de_Vries_syndrome.yaml |
87.3% | 89.5% | 62/71 | |
CTNNB1_Neurodevelopmental_Disorder.yaml |
87.3% | 88.6% | 200/229 | |
Argininosuccinic_Aciduria.yaml |
87.4% | 87.6% | 228/261 | |
Undetermined_Early_Onset_Epileptic_Encephalopathy.yaml |
87.4% | 89.1% | 83/95 | |
McKusick-Kaufman_Syndrome.yaml |
87.4% | 88.9% | 90/103 | |
Chronic_Primary_Adrenal_Insufficiency.yaml |
87.4% | 89.0% | 118/135 | |
Blepharophimosis-Impaired_Intellectual_Development_Syndrome.yaml |
87.5% | 89.4% | 105/120 | |
COX4I1-Related_COX_Deficiency.yaml |
87.5% | 89.9% | 63/72 | |
Clear_Cell_Ovarian_Carcinoma.yaml |
87.5% | 89.7% | 56/64 | |
Dorsalgia.yaml |
87.5% | 100.0% | 7/8 | |
Familial_Adenomatous_Polyposis.yaml |
87.5% | 88.6% | 77/88 | |
Leiomyosarcoma.yaml |
87.5% | 90.4% | 63/72 | |
Lichen_Simplex_Chronicus.yaml |
87.5% | 100.0% | 7/8 | |
MED13L_Syndrome.yaml |
87.5% | 87.4% | 329/376 | 1 |
Maroteaux-Lamy_syndrome.yaml |
87.5% | 89.1% | 91/104 | |
Postinfectious_Vasculitis.yaml |
87.5% | 90.3% | 77/88 | |
STRA6-related_syndromic_microphthalmia.yaml |
87.5% | 89.2% | 77/88 | |
Secondary_Hypertension.yaml |
87.5% | 100.0% | 7/8 | |
Urinary_Bladder_Small_Cell_Neuroendocrine_Carcinoma.yaml |
87.5% | 89.8% | 63/72 | |
Zlotogora-Ogur_Syndrome.yaml |
87.5% | 89.4% | 91/104 | |
Chordoma.yaml |
87.6% | 88.8% | 113/129 | |
Hepatic_Fibrinogen_Storage_Disease.yaml |
87.6% | 89.0% | 99/113 | |
Abetalipoproteinemia.yaml |
87.6% | 88.5% | 290/331 | |
Human_Papillomavirus_Infection.yaml |
87.6% | 89.8% | 85/97 | |
Irritable_Bowel_Syndrome.yaml |
87.6% | 87.9% | 85/97 | |
Xeroderma_Pigmentosum.yaml |
87.6% | 88.7% | 170/194 | |
Amelogenesis_Imperfecta.yaml |
87.7% | 88.2% | 71/81 | |
Chronic_Pancreatitis.yaml |
87.7% | 89.2% | 71/81 | |
Dissociative_Identity_Disorder.yaml |
87.7% | 89.5% | 64/73 | |
MYO6_Hearing_Loss.yaml |
87.7% | 88.1% | 64/73 | 1 |
Central_Retinal_Artery_Occlusion.yaml |
87.7% | 90.5% | 57/65 | |
Organophosphate_Poisoning.yaml |
87.7% | 88.9% | 150/171 | |
Dilated_Cardiomyopathy_2A.yaml |
87.7% | 89.9% | 143/163 | |
Spinocerebellar_Ataxia_27B.yaml |
87.7% | 89.6% | 179/204 | |
Chikungunya.yaml |
87.8% | 88.6% | 43/49 | |
Immunodeficiency_131.yaml |
87.8% | 89.6% | 86/98 | |
NUP62-Related_Infantile_Bilateral_Striatal_Necrosis.yaml |
87.8% | 90.1% | 43/49 | |
EGFR_Mutant_NSCLC.yaml |
87.8% | 87.9% | 201/229 | |
Emery_Dreifuss_Muscular_Dystrophy.yaml |
87.8% | 89.6% | 158/180 | |
Sea-Blue_Histiocyte_Syndrome.yaml |
87.8% | 89.5% | 79/90 | |
Malignant_Non_Dysgerminomatous_Germ_Cell_Tumor_Of_Ovary.yaml |
87.8% | 87.6% | 115/131 | 1 |
Chemotherapy_Induced_Neutropenia.yaml |
87.8% | 91.2% | 36/41 | |
Late_Complement_Component_Deficiency.yaml |
87.8% | 88.8% | 101/115 | |
Sweet_Syndrome.yaml |
87.8% | 89.6% | 101/115 | |
Fragile_X-Associated_Tremor_Ataxia_Syndrome.yaml |
87.8% | 89.9% | 130/148 | |
Niemann-Pick_Disease_Type_A.yaml |
87.8% | 90.0% | 65/74 | |
COX11-Related_COX_Deficiency.yaml |
87.9% | 90.7% | 29/33 | |
TBX6-Associated_Congenital_Scoliosis.yaml |
87.9% | 91.7% | 29/33 | |
Primary_Coenzyme_Q10_Deficiency.yaml |
87.9% | 89.5% | 102/116 | |
MRPL44_Deficiency.yaml |
87.9% | 88.3% | 226/257 | 2 |
GRIN1-Related_Neurodevelopmental_Disorder.yaml |
88.0% | 90.5% | 146/166 | |
Vitiligo.yaml |
88.0% | 86.5% | 190/216 | 4 |
Lissencephaly_Spectrum_Disorders.yaml |
88.0% | 89.5% | 161/183 | 2 |
Morgagni-Stewart-Morel_Syndrome.yaml |
88.0% | 88.7% | 132/150 | |
Genital_Lichen_Sclerosus.yaml |
88.0% | 90.2% | 81/92 | |
Beta_Mannosidosis.yaml |
88.1% | 89.4% | 111/126 | |
Primary_Progressive_Apraxia_of_Speech.yaml |
88.1% | 90.6% | 37/42 | |
Cauda_Equina_Syndrome.yaml |
88.1% | 89.1% | 89/101 | 1 |
Cherubism.yaml |
88.1% | 90.7% | 89/101 | |
CFAP418-related_Retinal_Ciliopathy.yaml |
88.2% | 90.4% | 67/76 | |
Ischemic_Stroke.yaml |
88.2% | 90.9% | 67/76 | |
Yolk_Sac_Tumor.yaml |
88.2% | 90.3% | 67/76 | |
D-Bifunctional_Protein_Deficiency.yaml |
88.2% | 89.6% | 82/93 | |
TGFBI_Corneal_Dystrophies.yaml |
88.2% | 89.5% | 82/93 | |
Pontiac_Fever.yaml |
88.2% | 88.5% | 97/110 | |
Alsahan-Harris_Syndrome.yaml |
88.2% | 90.5% | 60/68 | |
Buruli_Ulcer.yaml |
88.2% | 89.2% | 45/51 | |
Craniofacial-Deafness-Hand_Syndrome.yaml |
88.2% | 90.1% | 165/187 | |
DK1-congenital_disorder_of_glycosylation.yaml |
88.2% | 89.2% | 135/153 | |
Omphalocele.yaml |
88.2% | 90.3% | 75/85 | |
Pseudohypoparathyroidism.yaml |
88.2% | 90.1% | 120/136 | |
Wolf-Hirschhorn_Syndrome.yaml |
88.2% | 89.5% | 195/221 | |
Donnai-Barrow_syndrome.yaml |
88.3% | 89.8% | 113/128 | |
Familial_Sick_Sinus_Syndrome.yaml |
88.3% | 89.7% | 98/111 | |
PRPS1_Superactivity.yaml |
88.3% | 89.1% | 121/137 | |
Maculopapular_Cutaneous_Mastocytosis.yaml |
88.3% | 89.9% | 91/103 | |
Opitz_GBBB_Syndrome.yaml |
88.3% | 90.3% | 91/103 | |
Capillary_Malformation-Arteriovenous_Malformation_Syndrome.yaml |
88.4% | 91.3% | 76/86 | |
Osteogenesis_Imperfecta_Type_IV.yaml |
88.4% | 89.1% | 114/129 | |
GRIN2B-Related_Developmental_and_Epileptic_Encephalopathy.yaml |
88.4% | 90.8% | 99/112 | |
Chronic_Inflammatory_Demyelinating_Polyneuropathy.yaml |
88.4% | 90.6% | 61/69 | |
Posterior_Myocardial_Infarction.yaml |
88.4% | 87.8% | 61/69 | 1 |
Cardiofacioneurodevelopmental_Syndrome.yaml |
88.4% | 89.3% | 206/233 | |
Chronic_Obstructive_Pulmonary_Disease.yaml |
88.4% | 88.4% | 229/259 | 1 |
Lysosomal_Acid_Phosphatase_Deficiency.yaml |
88.5% | 92.3% | 23/26 | |
Migraine_with_Aura.yaml |
88.5% | 89.4% | 115/130 | |
Duchenne_Muscular_Dystrophy.yaml |
88.5% | 89.4% | 300/339 | 3 |
Transient_Neonatal_Pustular_Melanosis.yaml |
88.5% | 90.0% | 77/87 | |
Anauxetic_Dysplasia.yaml |
88.5% | 90.2% | 131/148 | |
Frias_Syndrome.yaml |
88.5% | 90.5% | 108/122 | |
SADDAN.yaml |
88.5% | 91.9% | 54/61 | |
Thymoma.yaml |
88.6% | 90.7% | 93/105 | |
CHIME_syndrome.yaml |
88.6% | 90.4% | 70/79 | |
IgA_Vasculitis.yaml |
88.6% | 90.7% | 109/123 | |
Vitamin_K_Dependent_Coagulation_Factor_Deficiency.yaml |
88.6% | 91.3% | 109/123 | |
Papular_Xanthoma.yaml |
88.6% | 90.2% | 39/44 | |
Postcricoid_Region_Cancer.yaml |
88.6% | 90.0% | 78/88 | |
Myalgic_Encephalomyelitis_Chronic_Fatigue_Syndrome.yaml |
88.7% | 91.9% | 125/141 | 1 |
Retinopathy_of_Prematurity.yaml |
88.7% | 91.6% | 47/53 | |
Schinzel-Giedion_Syndrome.yaml |
88.7% | 88.8% | 47/53 | |
Congenital_Diaphragmatic_Hernia.yaml |
88.7% | 89.1% | 306/345 | |
CAPOS_Syndrome.yaml |
88.7% | 90.0% | 212/239 | 2 |
Dilated_Cardiomyopathy_1Z.yaml |
88.7% | 89.9% | 220/248 | |
Silent_Sinus_Syndrome.yaml |
88.7% | 89.7% | 118/133 | |
Ochoa_Syndrome.yaml |
88.7% | 89.9% | 134/151 | |
Dysembryoplastic_Neuroepithelial_Tumor.yaml |
88.8% | 89.7% | 71/80 | 2 |
Thunderstorm_Asthma.yaml |
88.8% | 90.3% | 71/80 | 1 |
Juvenile_Open_Angle_Glaucoma.yaml |
88.8% | 90.6% | 79/89 | |
Early-Infantile_Developmental_and_Epileptic_Encephalopathy.yaml |
88.8% | 89.2% | 238/268 | 2 |
Addisons_Disease.yaml |
88.8% | 89.0% | 167/188 | 1 |
Autosomal_Recessive_Limb-Girdle_Muscular_Dystrophy.yaml |
88.9% | 90.7% | 112/126 | |
Autosomal_Recessive_Progressive_External_Ophthalmoplegia_1.yaml |
88.9% | 90.3% | 208/234 | |
Galactosialidosis.yaml |
88.9% | 91.1% | 88/99 | |
Legionnaires_Disease.yaml |
88.9% | 91.1% | 80/90 | |
SOX11-Related_Neurodevelopmental_Disorder.yaml |
88.9% | 90.0% | 248/279 | |
Triosephosphate_Isomerase_Deficiency.yaml |
88.9% | 90.8% | 56/63 | |
Whipple_Disease.yaml |
88.9% | 90.9% | 104/117 | |
neuroferritinopathy.yaml |
88.9% | 89.7% | 96/108 | |
Autoimmune_Pulmonary_Alveolar_Proteinosis.yaml |
88.9% | 89.9% | 209/235 | 1 |
Autosomal_Dominant_Polycystic_Liver_Disease.yaml |
88.9% | 89.8% | 169/190 | |
Galloway-Mowat_Syndrome.yaml |
89.0% | 90.4% | 202/227 | |
PPM-X_Syndrome.yaml |
89.0% | 90.1% | 202/227 | |
Hantavirus_Pulmonary_Syndrome.yaml |
89.0% | 90.5% | 97/109 | |
Claes-Jensen_Type_X-Linked_Intellectual_Disability.yaml |
89.0% | 90.4% | 243/273 | |
Otopalatodigital_Spectrum_Disorders.yaml |
89.0% | 91.0% | 81/91 | |
STAG3-related_gametogenic_failure.yaml |
89.0% | 90.5% | 65/73 | |
Multiminicore_Disease.yaml |
89.1% | 90.8% | 114/128 | |
NARP_syndrome.yaml |
89.1% | 89.4% | 106/119 | 1 |
Mosaic_Variegated_Aneuploidy_Syndrome.yaml |
89.1% | 89.7% | 196/220 | |
Marchiafava_Bignami_Disease.yaml |
89.1% | 90.4% | 90/101 | |
Penttinen_Premature_Aging_Syndrome.yaml |
89.1% | 91.2% | 41/46 | |
TNF_Receptor-Associated_Periodic_Syndrome.yaml |
89.1% | 89.9% | 123/138 | 2 |
Medulloblastoma_SHH_Activated.yaml |
89.2% | 91.5% | 74/83 | |
MECP2_Duplication_Syndrome.yaml |
89.2% | 90.6% | 107/120 | |
Chronic_Granulomatous_Disease.yaml |
89.2% | 90.5% | 140/157 | |
Jackson-Weiss_Syndrome.yaml |
89.2% | 91.1% | 66/74 | |
Neuronal_Ceroid_Lipofuscinosis_2.yaml |
89.2% | 91.2% | 66/74 | |
Malignant_Hyperthermia_of_Anesthesia.yaml |
89.2% | 90.1% | 124/139 | 4 |
Spondyloepiphyseal_Dysplasia_Congenita.yaml |
89.3% | 90.2% | 191/214 | |
Alternating_Hemiplegia_of_Childhood.yaml |
89.3% | 89.7% | 108/121 | |
Adenylosuccinate_Lyase_Deficiency.yaml |
89.3% | 89.5% | 225/252 | |
Murine_Typhus.yaml |
89.3% | 91.0% | 142/159 | |
Diabetic_Retinopathy.yaml |
89.3% | 90.8% | 92/103 | |
Malaria.yaml |
89.3% | 90.4% | 159/178 | 1 |
Clear_Cell_Sarcoma.yaml |
89.3% | 91.6% | 67/75 | |
Monomelic_Amyotrophy.yaml |
89.3% | 91.4% | 67/75 | |
Costello_Syndrome.yaml |
89.4% | 89.6% | 168/188 | 1 |
Treacher_Collins_Syndrome.yaml |
89.4% | 90.2% | 126/141 | 1 |
Angiosarcoma.yaml |
89.4% | 89.9% | 177/198 | |
Brugada_Syndrome.yaml |
89.4% | 89.7% | 118/132 | 4 |
Greig_Cephalopolysyndactyly.yaml |
89.4% | 92.0% | 76/85 | |
Multiple_Sclerosis.yaml |
89.5% | 90.0% | 263/294 | 1 |
3-Hydroxyisobutyryl-CoA_Hydrolase_Deficiency.yaml |
89.5% | 88.8% | 221/247 | 2 |
ALG3-Congenital_Disorder_of_Glycosylation.yaml |
89.5% | 91.4% | 102/114 | |
Chronic_Traumatic_Encephalopathy.yaml |
89.5% | 92.9% | 34/38 | |
IFT140-related_Recessive_Ciliopathy.yaml |
89.5% | 91.1% | 85/95 | |
PHARC_syndrome.yaml |
89.5% | 90.3% | 94/105 | 1 |
Follicular_Lymphoma.yaml |
89.5% | 90.8% | 137/153 | |
Ectodermal_Dysplasia_and_Immunodeficiency_2.yaml |
89.6% | 91.3% | 86/96 | |
Hereditary_Hemorrhagic_Telangiectasia.yaml |
89.6% | 91.0% | 155/173 | |
Free_Sialic_Acid_Storage_Disease.yaml |
89.6% | 90.3% | 181/202 | |
Peutz_Jeghers_Syndrome.yaml |
89.6% | 90.9% | 181/202 | |
Primary_Polyarteritis_Nodosa.yaml |
89.6% | 88.8% | 69/77 | 3 |
Primary_Cutaneous_Amyloidosis.yaml |
89.7% | 90.7% | 234/261 | |
Seckel_Syndrome.yaml |
89.7% | 91.5% | 78/87 | |
Temporal_Lobe_Epilepsy.yaml |
89.7% | 93.7% | 26/29 | |
USP9X_Female-Restricted_Syndromic_Intellectual_Disability.yaml |
89.7% | 90.9% | 347/387 | |
Split_Hand_Foot_Malformation.yaml |
89.7% | 92.0% | 113/126 | |
Junctional_Epidermolysis_Bullosa.yaml |
89.7% | 90.5% | 174/194 | |
MCM8-related_gametogenic_failure.yaml |
89.7% | 91.1% | 87/97 | |
VCP-associated_Multisystem_Proteinopathy.yaml |
89.7% | 90.3% | 148/165 | |
Oculogastrointestinal-Neurodevelopmental_Syndrome.yaml |
89.7% | 92.1% | 61/68 | |
Fountain_Syndrome.yaml |
89.7% | 90.5% | 105/117 | |
Microphthalmia_with_Coloboma.yaml |
89.7% | 91.4% | 105/117 | |
WAGR_Syndrome.yaml |
89.8% | 91.3% | 114/127 | |
Scarlet_Fever.yaml |
89.8% | 90.5% | 79/88 | 1 |
Primary_Hyperoxaluria_Type_1.yaml |
89.8% | 92.5% | 44/49 | |
Primary_Hyperoxaluria_Type_2.yaml |
89.8% | 92.4% | 44/49 | |
Choroid_Plexus_Carcinoma.yaml |
89.8% | 91.1% | 97/108 | |
Cadmium_Poisoning.yaml |
89.8% | 90.3% | 256/285 | 1 |
Familial_Sleep_Related_Hypermotor_Epilepsy.yaml |
89.8% | 91.4% | 159/177 | |
Juvenile_Temporal_Arteritis.yaml |
89.8% | 89.1% | 53/59 | 2 |
Arrhythmogenic_Right_Ventricular_Cardiomyopathy.yaml |
89.9% | 89.7% | 257/286 | 3 |
Carotid_Artery_Occlusion.yaml |
89.9% | 91.8% | 71/79 | 1 |
Dextro_Transposition_of_the_Great_Arteries.yaml |
89.9% | 91.3% | 71/79 | |
Fallopian_Tube_Benign_Neoplasm.yaml |
89.9% | 90.1% | 80/89 | 1 |
Benign_Familial_Infantile_Epilepsy.yaml |
89.9% | 89.2% | 187/208 | 2 |
LAMB1-Related_Cobblestone_Lissencephaly.yaml |
89.9% | 91.5% | 107/119 | |
Immunodeficiency_Centromeric_Instability_Facial_Anomalies_Syndrome.yaml |
89.9% | 90.7% | 223/248 | |
Erythropoietic_Protoporphyria.yaml |
89.9% | 91.4% | 116/129 | |
Neuronal_Ceroid_Lipofuscinosis_3.yaml |
89.9% | 92.0% | 116/129 | |
Polycystic_Kidney_Disease.yaml |
89.9% | 89.7% | 241/268 | 1 |
Thomsen_and_Becker_disease.yaml |
89.9% | 90.7% | 125/139 | 1 |
Adenomyosis.yaml |
89.9% | 91.0% | 170/189 | |
B-Lymphoblastic_Leukemia_Lymphoma_With_Recurrent_Genetic_Abnormality.yaml |
89.9% | 90.7% | 170/189 | |
Kabuki_Syndrome.yaml |
90.0% | 90.2% | 269/299 | |
PRKAG2_Cardiac_Syndrome.yaml |
90.0% | 91.2% | 269/299 | |
Essential_Tremor.yaml |
90.0% | 91.7% | 90/100 | |
Glanders.yaml |
90.0% | 91.0% | 54/60 | |
Huppke-Brendel_syndrome.yaml |
90.0% | 91.3% | 99/110 | |
Hypokalemic_Periodic_Paralysis.yaml |
90.0% | 92.5% | 90/100 | |
MCM9-related_gametogenic_failure.yaml |
90.0% | 92.1% | 90/100 | |
Manganism.yaml |
90.0% | 94.7% | 18/20 | |
Mobitz_Type_I_Atrioventricular_Block.yaml |
90.0% | 92.7% | 45/50 | |
Mycetoma.yaml |
90.0% | 92.9% | 72/80 | |
STAT2_Deficiency.yaml |
90.0% | 93.1% | 36/40 | |
Sezary_Syndrome.yaml |
90.0% | 91.1% | 108/120 | |
Inclusion_Body_Myositis.yaml |
90.0% | 91.8% | 271/301 | |
Early-Onset_Autosomal_Dominant_Alzheimer_Disease.yaml |
90.0% | 90.7% | 235/261 | |
Schizophrenia.yaml |
90.0% | 88.7% | 208/231 | 3 |
Systemic_Lupus_Erythematosus.yaml |
90.0% | 89.2% | 398/442 | 4 |
Neuronal_Ceroid_Lipofuscinosis_7.yaml |
90.1% | 90.8% | 118/131 | 1 |
Blepharophimosis_Ptosis_and_Epicanthus_Inversus_Syndrome.yaml |
90.1% | 91.6% | 109/121 | |
Cerebral_Cavernous_Malformation.yaml |
90.1% | 91.5% | 82/91 | 1 |
Charcot-Marie-Tooth_Disease_Type_1.yaml |
90.1% | 91.9% | 82/91 | |
Klinefelter_Syndrome.yaml |
90.1% | 90.2% | 155/172 | 1 |
NELABA.yaml |
90.1% | 91.3% | 155/172 | |
Trichothiodystrophy.yaml |
90.1% | 92.2% | 73/81 | |
Allopurinol_Induced_SJS_TEN.yaml |
90.2% | 92.9% | 55/61 | |
Anal_Canal_Carcinoma.yaml |
90.2% | 92.2% | 101/112 | |
Kennedy_Disease.yaml |
90.2% | 92.2% | 101/112 | |
Acute_Macular_Neuroretinopathy.yaml |
90.2% | 93.6% | 46/51 | |
Pilarowski-Bjornsson_syndrome.yaml |
90.2% | 91.7% | 92/102 | |
Familial_Cold_Autoinflammatory_Syndrome.yaml |
90.2% | 91.3% | 120/133 | |
CN_Related_DEE.yaml |
90.2% | 91.6% | 111/123 | 1 |
Fuchs_Endothelial_Corneal_Dystrophy.yaml |
90.2% | 91.4% | 148/164 | |
SYCE1_Related_Gametogenic_Failure.yaml |
90.2% | 91.9% | 74/82 | |
Lichtenstein-Knorr_Syndrome.yaml |
90.3% | 91.2% | 65/72 | 1 |
Schwannoma.yaml |
90.3% | 91.9% | 93/103 | |
Anencephaly.yaml |
90.3% | 91.7% | 84/93 | |
Corpus_Callosum_Agenesis-Intellectual_Disability-Coloboma-Micrognathia_Syndrome.yaml |
90.3% | 91.4% | 112/124 | |
Oculocutaneous_Albinism.yaml |
90.3% | 91.6% | 131/145 | |
Congenital_Pulmonary_Airway_Malformation.yaml |
90.4% | 91.4% | 103/114 | |
BRCA_Mutant_Prostate_Cancer.yaml |
90.4% | 90.2% | 197/218 | 1 |
Transitional_Cell_Carcinoma.yaml |
90.4% | 91.8% | 113/125 | |
Creatine_Transporter_Deficiency.yaml |
90.5% | 92.7% | 57/63 | |
RAB5C-Related_Neurodevelopmental_Disorder_with_Macrocephaly.yaml |
90.5% | 93.3% | 38/42 | |
Spondylocostal_Dysostosis.yaml |
90.5% | 92.1% | 95/105 | |
Liposarcoma.yaml |
90.5% | 92.1% | 105/116 | |
KCNH1_Associated_Disorder.yaml |
90.5% | 92.1% | 172/190 | |
Brucellosis.yaml |
90.5% | 90.3% | 249/275 | 2 |
Left_Ventricular_Noncompaction.yaml |
90.6% | 91.6% | 115/127 | |
Splenic_Artery_Aneurysm.yaml |
90.6% | 92.0% | 96/106 | 1 |
Cole-Carpenter_Syndrome.yaml |
90.6% | 92.2% | 106/117 | |
DPM2-congenital_disorder_of_glycosylation.yaml |
90.6% | 92.3% | 232/256 | |
Phelan-McDermid_Syndrome.yaml |
90.6% | 91.1% | 87/96 | |
Encephalocraniocutaneous_Lipomatosis.yaml |
90.7% | 91.6% | 68/75 | |
Essential_Hypertension.yaml |
90.7% | 91.8% | 68/75 | |
Pallister-Hall_Syndrome.yaml |
90.7% | 93.0% | 68/75 | |
Wilms_Tumor.yaml |
90.7% | 91.2% | 204/225 | 1 |
Nijmegen_Breakage_Syndrome-like_Disorder.yaml |
90.7% | 91.7% | 253/279 | |
Epidermolysis_Bullosa_Simplex.yaml |
90.7% | 91.5% | 146/161 | |
Holoprosencephaly_9.yaml |
90.7% | 91.6% | 254/280 | |
Inherited_Porphyria.yaml |
90.7% | 91.4% | 215/237 | |
Carotid_Stenosis.yaml |
90.7% | 93.2% | 88/97 | 1 |
Double_Outlet_Right_Ventricle.yaml |
90.8% | 91.3% | 314/346 | |
Cerebral_Amyloid_Angiopathy.yaml |
90.8% | 92.1% | 108/119 | |
Lipoyl_Transferase_1_Deficiency.yaml |
90.8% | 92.0% | 108/119 | |
Progressive_Familial_Heart_Block.yaml |
90.8% | 94.1% | 69/76 | |
SMAD6-related_Craniosynostosis.yaml |
90.8% | 91.6% | 89/98 | |
Cholera.yaml |
90.8% | 89.6% | 297/327 | 1 |
Benign_Neonatal_Seizures.yaml |
90.9% | 90.5% | 219/241 | 2 |
Anti-GBM_Disease.yaml |
90.9% | 92.2% | 90/99 | 1 |
Autosomal_Dominant_Hyper-IgE_Syndrome.yaml |
90.9% | 92.3% | 150/165 | |
Dental_Fluorosis.yaml |
90.9% | 93.2% | 50/55 | |
Endometrial_Endometrioid_Adenocarcinoma.yaml |
90.9% | 92.1% | 120/132 | |
Growth_Hormone_Insensitivity_Syndrome.yaml |
90.9% | 92.1% | 110/121 | |
KCNV2_Related_Retinopathy.yaml |
90.9% | 94.4% | 30/33 | |
Mucopolysaccharidosis_type_IX.yaml |
90.9% | 93.1% | 50/55 | |
Nijmegen_breakage_syndrome.yaml |
90.9% | 92.4% | 70/77 | |
Prurigo_Nodularis.yaml |
90.9% | 100.0% | 10/11 | |
SLC13A5_Citrate_Transporter_Disorder.yaml |
90.9% | 92.8% | 100/110 | |
VPS53-Related_Pontocerebellar_Hypoplasia_Type_2E.yaml |
90.9% | 93.1% | 60/66 | |
5-Oxoprolinase_Deficiency.yaml |
91.0% | 92.4% | 121/133 | |
Mucopolysaccharidosis.yaml |
91.0% | 92.5% | 152/167 | |
Patent_Ductus_Arteriosus.yaml |
91.0% | 93.4% | 71/78 | |
Folliculitis.yaml |
91.1% | 94.0% | 265/291 | |
Cerebral_Proliferative_Angiopathy.yaml |
91.1% | 91.7% | 51/56 | 1 |
Laryngotracheoesophageal_Cleft.yaml |
91.1% | 93.8% | 153/168 | |
Empty_Nose_Syndrome.yaml |
91.1% | 91.3% | 143/157 | 1 |
Cystic_Fibrosis.yaml |
91.1% | 91.3% | 501/550 | |
Narcolepsy.yaml |
91.1% | 92.2% | 82/90 | |
Sneddon_syndrome.yaml |
91.1% | 93.8% | 41/45 | |
MITF_Waardenburg_Tietz_Spectrum.yaml |
91.1% | 93.1% | 72/79 | |
Uveal_Coloboma-Cleft_Lip_and_Palate-Intellectual_Disability_Syndrome.yaml |
91.1% | 92.4% | 144/158 | |
Pancreatic_Neuroendocrine_Tumor.yaml |
91.2% | 92.4% | 103/113 | |
Idiopathic_Triglyceride_Deposit_Cardiomyovasculopathy.yaml |
91.2% | 95.4% | 31/34 | |
MAN2C1-congenital_disorder_of_deglycosylation_2.yaml |
91.2% | 94.2% | 31/34 | |
UGP2-Related_Developmental_and_Epileptic_Encephalopathy_83.yaml |
91.2% | 94.3% | 31/34 | |
Microcephaly-Capillary_Malformation_Syndrome.yaml |
91.2% | 92.6% | 321/352 | |
Antisynthetase_Syndrome.yaml |
91.2% | 92.8% | 145/159 | |
Obsessive-Compulsive_Disorder.yaml |
91.2% | 92.1% | 156/171 | |
Pineoblastoma.yaml |
91.3% | 92.6% | 94/103 | |
Arginase_Deficiency.yaml |
91.3% | 91.6% | 315/345 | |
Colon_Adenocarcinoma.yaml |
91.3% | 90.0% | 21/23 | 1 |
Familial_Exudative_Vitreoretinopathy.yaml |
91.3% | 92.8% | 147/161 | |
Peroxisomal_Acyl-CoA_Oxidase_Deficiency.yaml |
91.3% | 92.1% | 168/184 | |
Cernunnos-XLF_deficiency.yaml |
91.4% | 93.0% | 74/81 | |
Paralytic_Poliomyelitis.yaml |
91.4% | 93.2% | 74/81 | |
Carbon_Monoxide_Poisoning.yaml |
91.4% | 92.5% | 159/174 | |
Familial_Vesicoureteral_Reflux.yaml |
91.4% | 92.7% | 297/325 | |
Brachydactyly_Type_A1.yaml |
91.4% | 92.2% | 149/163 | |
GJB2-GJB6_Digenic_Nonsyndromic_Hearing_Loss.yaml |
91.4% | 94.3% | 32/35 | |
Striate_Palmoplantar_Keratoderma_Type_2.yaml |
91.4% | 91.4% | 171/187 | 1 |
Malignant_Peritoneal_Mesothelioma.yaml |
91.5% | 92.6% | 107/117 | |
MET_Exon_14_Skipping_NSCLC.yaml |
91.5% | 93.9% | 75/82 | |
D-2-Hydroxyglutaric_Aciduria.yaml |
91.5% | 93.3% | 237/259 | 1 |
Eosinophilic_Esophagitis.yaml |
91.5% | 93.3% | 97/106 | |
Hydatidiform_Mole.yaml |
91.5% | 93.4% | 54/59 | |
Gaucher_Disease.yaml |
91.5% | 91.5% | 260/284 | 1 |
MOGAD.yaml |
91.5% | 92.6% | 130/142 | |
Primary_Hyperoxaluria_Type_3.yaml |
91.5% | 93.1% | 65/71 | |
Aortitis.yaml |
91.6% | 91.5% | 239/261 | 1 |
IgG4-Related_Sclerosing_Cholangitis.yaml |
91.6% | 92.8% | 87/95 | 1 |
Autoimmune_Enteropathy.yaml |
91.6% | 93.3% | 120/131 | |
Otomycosis.yaml |
91.6% | 91.5% | 131/143 | 2 |
RYR2_CPVT.yaml |
91.6% | 92.7% | 164/179 | |
Inflammatory_Myofibroblastic_Tumor.yaml |
91.7% | 93.4% | 88/96 | |
MELAS_Syndrome.yaml |
91.7% | 93.2% | 110/120 | |
Osteogenesis_Imperfecta_Type_VI.yaml |
91.7% | 93.3% | 77/84 | |
PAX3_Waardenburg_Spectrum.yaml |
91.7% | 92.6% | 99/108 | 1 |
Primary_Hypertrophic_Osteoarthropathy.yaml |
91.7% | 93.1% | 99/108 | |
Social_Anxiety_Disorder.yaml |
91.7% | 89.0% | 132/144 | 3 |
UGGT1-congenital_disorder_of_glycosylation.yaml |
91.7% | 96.1% | 44/48 | |
PUS3-Related_Neurodevelopmental_Disorder.yaml |
91.7% | 93.2% | 188/205 | |
Hereditary_Spastic_Paraplegia.yaml |
91.7% | 93.1% | 144/157 | |
Vogt-Koyanagi-Harada_Disease.yaml |
91.7% | 93.4% | 111/121 | |
3-Methylglutaconic_Aciduria_Type_I.yaml |
91.8% | 92.3% | 168/183 | |
Hermansky_Pudlak_Syndrome.yaml |
91.8% | 93.6% | 168/183 | |
Osteonecrosis.yaml |
91.8% | 93.7% | 112/122 | |
Disorder_of_Catecholamine_Synthesis.yaml |
91.8% | 92.3% | 202/220 | |
Sinoatrial_Node_Dysfunction_and_Deafness.yaml |
91.8% | 92.9% | 180/196 | |
Non-functional_Pancreatic_Neuroendocrine_Tumor.yaml |
91.9% | 93.5% | 79/86 | |
Pacak-Zhuang_syndrome.yaml |
91.9% | 93.0% | 79/86 | |
Microcephalic_Osteodysplastic_Primordial_Dwarfism_Type_I.yaml |
91.9% | 93.1% | 147/160 | |
Soil_Transmitted_Helminthiases.yaml |
91.9% | 92.3% | 68/74 | |
Vulvar_Adenocarcinoma.yaml |
91.9% | 93.0% | 102/111 | |
Yaws.yaml |
91.9% | 94.8% | 34/37 | |
Microcephalic_Osteodysplastic_Primordial_Dwarfism_Type_II.yaml |
91.9% | 93.6% | 159/173 | |
Endometrial_Carcinoma.yaml |
91.9% | 93.1% | 171/186 | |
Ocular_Melanoma.yaml |
92.0% | 93.0% | 298/324 | |
Cutaneous_Collagenous_Vasculopathy.yaml |
92.0% | 91.2% | 46/50 | 2 |
Incontinentia_Pigmenti.yaml |
92.0% | 93.3% | 138/150 | |
Parenti-Mignot_Neurodevelopmental_Syndrome.yaml |
92.0% | 93.6% | 92/100 | |
Vulvar_Carcinoma.yaml |
92.0% | 92.4% | 115/125 | 1 |
Hypertensive_Heart_Disease.yaml |
92.0% | 91.6% | 196/213 | 1 |
Rhizomelic_Chondrodysplasia_Punctata_Plasmalogen_Synthesis_Defect.yaml |
92.0% | 94.1% | 127/138 | |
Fibrocartilaginous_Embolism.yaml |
92.1% | 92.5% | 58/63 | 1 |
Osteogenesis_Imperfecta_Type_VIII.yaml |
92.1% | 94.2% | 58/63 | |
Myopathy_Lactic_Acidosis_and_Sideroblastic_Anemia.yaml |
92.1% | 92.5% | 244/265 | |
Bainbridge-Ropers_Syndrome.yaml |
92.1% | 93.7% | 279/303 | |
Choroiditis.yaml |
92.1% | 92.5% | 338/367 | |
Charlevoix-Saguenay_spastic_ataxia.yaml |
92.1% | 93.1% | 140/152 | |
Psittacosis.yaml |
92.1% | 95.0% | 35/38 | |
Autosomal_Recessive_Non-Syndromic_Intellectual_Disability.yaml |
92.1% | 92.3% | 340/369 | 1 |
Camurati-Engelmann_Disease.yaml |
92.2% | 93.5% | 141/153 | |
Giardiasis.yaml |
92.2% | 94.2% | 236/256 | |
Proteasome_Associated_Autoinflammatory_Syndrome.yaml |
92.2% | 93.9% | 59/64 | |
Leber_Hereditary_Optic_Neuropathy.yaml |
92.2% | 92.8% | 272/295 | 1 |
Satoyoshi_Syndrome.yaml |
92.2% | 92.6% | 166/180 | 1 |
Eosinophilic_Fasciitis.yaml |
92.2% | 93.7% | 107/116 | |
Keratoderma_Hereditarium_Mutilans.yaml |
92.2% | 92.4% | 107/116 | 1 |
Apert_Syndrome.yaml |
92.3% | 93.2% | 143/155 | |
THOC6-Related_Developmental_Delay-Microcephaly-Facial_Dysmorphism_Syndrome.yaml |
92.3% | 93.6% | 155/168 | 1 |
Mucopolysaccharidosis-Plus_Syndrome.yaml |
92.3% | 93.4% | 239/259 | |
Lowe_Syndrome.yaml |
92.3% | 93.4% | 96/104 | |
Mucoepidermoid_Carcinoma.yaml |
92.3% | 94.3% | 60/65 | |
Myofibrillar_Myopathy.yaml |
92.3% | 93.2% | 348/377 | |
ROS1_Rearranged_NSCLC.yaml |
92.3% | 93.0% | 168/182 | |
Raynaud_Disease.yaml |
92.3% | 96.3% | 84/91 | |
Rothmund-Thomson_Syndrome.yaml |
92.3% | 93.7% | 108/117 | |
Rienhoff_Syndrome.yaml |
92.3% | 93.5% | 217/235 | |
Squamous_Cell_Carcinoma_of_Penis.yaml |
92.4% | 93.7% | 85/92 | |
TARP_syndrome.yaml |
92.4% | 94.6% | 85/92 | |
Peripheral_T_Cell_Lymphoma.yaml |
92.4% | 93.3% | 158/171 | |
Autosomal_Dominant_Non-Syndromic_Intellectual_Disability.yaml |
92.4% | 93.5% | 220/238 | |
HSD10_Mitochondrial_Disease.yaml |
92.5% | 93.9% | 98/106 | |
Psoriasis_14_Pustular.yaml |
92.5% | 94.7% | 49/53 | |
STING_Associated_Vasculopathy_with_Onset_in_Infancy.yaml |
92.5% | 94.6% | 49/53 | |
Lathyrism.yaml |
92.5% | 93.8% | 135/146 | |
Pick_Disease.yaml |
92.5% | 93.4% | 135/146 | |
Ferguson-Bonni_Neurodevelopmental_Syndrome.yaml |
92.5% | 93.5% | 136/147 | |
Cannabis_Hyperemesis_Syndrome.yaml |
92.5% | 93.7% | 99/107 | |
Mantle_Cell_Lymphoma.yaml |
92.5% | 93.9% | 198/214 | |
Congenital_Insensitivity_to_Pain.yaml |
92.6% | 93.9% | 125/135 | |
IKBKG_Ectodermal_Dysplasia_with_Immunodeficiency.yaml |
92.6% | 93.9% | 125/135 | |
Niemann-Pick_Disease_Type_E.yaml |
92.6% | 96.2% | 25/27 | |
Bilateral_Striopallidodentate_Calcinosis.yaml |
92.6% | 93.9% | 113/122 | |
Duane_Retraction_Syndrome.yaml |
92.6% | 94.2% | 88/95 | |
Gestational_Trophoblastic_Neoplasm.yaml |
92.6% | 94.4% | 88/95 | |
CHD8-Related_Neurodevelopmental_Disorder_with_Overgrowth.yaml |
92.6% | 93.6% | 340/367 | |
Progressive_Bulbar_Palsy.yaml |
92.6% | 94.8% | 63/68 | |
Bullous_Pemphigoid.yaml |
92.7% | 94.3% | 101/109 | |
Cerebellar_Ataxia-Hypogonadism_Syndrome.yaml |
92.7% | 93.9% | 152/164 | |
3-Hydroxy-3-Methylglutaric_Aciduria.yaml |
92.7% | 93.2% | 241/260 | |
CHST3-Related_Skeletal_Dysplasia.yaml |
92.7% | 94.1% | 203/219 | |
Progressive_Supranuclear_Palsy.yaml |
92.7% | 94.1% | 140/151 | |
Isolated_Sulfite_Oxidase_Deficiency.yaml |
92.7% | 94.0% | 242/261 | |
Crouzon_Syndrome.yaml |
92.7% | 94.1% | 102/110 | |
Meningeal_Melanocytoma.yaml |
92.7% | 93.7% | 102/110 | 1 |
Taeniasis_Cysticercosis.yaml |
92.7% | 93.7% | 51/55 | |
Deafness-Lymphedema-Leukemia_Syndrome.yaml |
92.8% | 93.4% | 128/138 | |
GOLGA2-Related_Golgin_A2_Deficiency.yaml |
92.8% | 94.8% | 64/69 | |
Cryoglobulinemic_Vasculitis.yaml |
92.8% | 92.8% | 90/97 | 2 |
Shigellosis.yaml |
92.8% | 93.5% | 103/111 | |
Fanconi_Renotubular_Syndrome.yaml |
92.8% | 94.0% | 129/139 | |
Leprosy.yaml |
92.8% | 93.9% | 129/139 | |
Adult_Onset_Foveomacular_Vitelliform_Dystrophy.yaml |
92.9% | 94.2% | 91/98 | |
Chemotherapy_Induced_Nausea_and_Vomiting.yaml |
92.9% | 94.2% | 65/70 | |
NGLY1-congenital_disorder_of_deglycosylation.yaml |
92.9% | 95.0% | 52/56 | |
Renpenning_syndrome.yaml |
92.9% | 94.7% | 65/70 | |
Diabetes_Mellitus.yaml |
92.9% | 92.8% | 340/366 | 2 |
Bardet-Biedl_Syndrome.yaml |
92.9% | 93.5% | 288/310 | |
Lipoic_Acid_Synthetase_Deficiency.yaml |
92.9% | 94.3% | 118/127 | |
Hepatic_Veno-occlusive_Disease-Immunodeficiency_Syndrome.yaml |
92.9% | 94.4% | 92/99 | |
Segmental_Arterial_Mediolysis.yaml |
92.9% | 93.3% | 79/85 | 1 |
Meckel_Syndrome.yaml |
93.0% | 94.0% | 211/227 | |
Cough_Variant_Asthma.yaml |
93.0% | 94.6% | 66/71 | |
Keipert_syndrome.yaml |
93.0% | 94.8% | 66/71 | |
Non-Small_Cell_Lung_Cancer.yaml |
93.0% | 91.8% | 185/199 | 2 |
Rheumatoid_Vasculitis.yaml |
93.0% | 93.8% | 106/114 | 2 |
Salla_Disease.yaml |
93.0% | 93.9% | 159/171 | 1 |
Hidradenitis_Suppurativa.yaml |
93.0% | 94.3% | 253/272 | |
Carvajal_Syndrome.yaml |
93.0% | 94.2% | 120/129 | |
Premenstrual_Dysphoric_Disorder.yaml |
93.0% | 94.2% | 147/158 | |
Meier-Gorlin_Syndrome.yaml |
93.0% | 94.0% | 281/302 | |
Autism_Susceptibility_to_X-Linked_3.yaml |
93.1% | 94.7% | 67/72 | |
Primary_Erythermalgia.yaml |
93.1% | 94.3% | 67/72 | |
Dilated_Cardiomyopathy.yaml |
93.1% | 93.9% | 256/275 | |
PUS7-Related_Neurodevelopmental_Disorder.yaml |
93.1% | 94.5% | 283/304 | |
Aneurysm-Osteoarthritis_Syndrome.yaml |
93.1% | 94.1% | 135/145 | |
Panic_Disorder.yaml |
93.1% | 93.3% | 108/116 | |
ReNU_Syndrome.yaml |
93.1% | 94.7% | 108/116 | |
Citrin_Deficiency.yaml |
93.1% | 93.4% | 230/247 | 1 |
Kindler_Epidermolysis_Bullosa.yaml |
93.1% | 93.7% | 149/160 | |
Multiple_Epiphyseal_Dysplasia.yaml |
93.1% | 94.2% | 149/160 | |
Pulmonary_Hemosiderosis.yaml |
93.2% | 94.3% | 177/190 | |
Spinocerebellar_Ataxia_43.yaml |
93.2% | 94.4% | 109/117 | 1 |
Vertebral_Artery_Insufficiency.yaml |
93.2% | 94.5% | 109/117 | |
Chediak-Higashi_Syndrome.yaml |
93.2% | 94.6% | 123/132 | |
Coronary_Arterial_Fistulas.yaml |
93.2% | 94.0% | 41/44 | 1 |
Coronary_Vasospasm.yaml |
93.2% | 94.7% | 82/88 | |
Gaucher_Disease_Due_To_Saposin_C_Deficiency.yaml |
93.2% | 95.6% | 41/44 | |
Granulomatosis_with_Polyangiitis.yaml |
93.2% | 94.3% | 274/294 | |
Mitochondrial_Trifunctional_Protein_Deficiency.yaml |
93.2% | 93.4% | 247/265 | 1 |
Common_Variable_Immunodeficiency.yaml |
93.2% | 94.6% | 110/118 | |
Congenital_Heart_Defects_and_Skeletal_Malformations_Syndrome.yaml |
93.3% | 94.2% | 249/267 | |
Alveolar_Soft_Part_Sarcoma.yaml |
93.3% | 94.3% | 97/104 | |
Chondrosarcoma.yaml |
93.3% | 95.2% | 97/104 | |
Barth_Syndrome.yaml |
93.3% | 94.0% | 153/164 | |
Dracunculiasis.yaml |
93.3% | 92.9% | 56/60 | 1 |
Hypochondrogenesis.yaml |
93.3% | 94.1% | 168/180 | |
Malnutrition-related_Diabetes_Mellitus.yaml |
93.3% | 100.0% | 14/15 | |
Mercury_Poisoning.yaml |
93.3% | 96.9% | 28/30 | |
Microcephaly_Short_Stature_and_Impaired_Glucose_Metabolism_2.yaml |
93.3% | 94.7% | 182/195 | |
Proliferative_Vitreoretinopathy.yaml |
93.3% | 95.5% | 56/60 | |
UGDH-Related_Developmental_and_Epileptic_Encephalopathy_84.yaml |
93.3% | 95.9% | 42/45 | |
PTCH1-related_Nevoid_Basal_Cell_Carcinoma_Syndrome.yaml |
93.4% | 94.2% | 85/91 | |
Choroid_Plexus_Neoplasm.yaml |
93.4% | 93.9% | 326/349 | |
Familial_Hypercholesterolemia.yaml |
93.4% | 93.5% | 397/425 | 2 |
Naxos_disease.yaml |
93.4% | 94.7% | 142/152 | |
Phenylketonuria.yaml |
93.4% | 94.2% | 455/487 | |
Familial_Hyperaldosteronism.yaml |
93.4% | 94.6% | 128/137 | |
Ornithine_Carbamoyltransferase_Deficiency.yaml |
93.5% | 94.0% | 200/214 | |
ADan_amyloidosis.yaml |
93.5% | 93.7% | 229/245 | |
Central_Nervous_System_Teratoma.yaml |
93.5% | 94.1% | 129/138 | 1 |
Mitochondrial_DNA_Depletion_Syndrome_7.yaml |
93.5% | 95.2% | 86/92 | |
Isobutyryl-CoA_Dehydrogenase_Deficiency.yaml |
93.5% | 93.8% | 201/215 | 1 |
Sly_syndrome.yaml |
93.5% | 95.6% | 101/108 | |
Pleuropulmonary_Blastoma.yaml |
93.5% | 94.7% | 130/139 | |
Contact_Dermatitis.yaml |
93.5% | 95.6% | 217/232 | |
Congenital_Myasthenic_Syndrome.yaml |
93.5% | 94.6% | 174/186 | |
Hereditary_Neuropathy_with_Liability_to_Pressure_Palsies.yaml |
93.5% | 94.1% | 87/93 | |
Osteogenesis_Imperfecta_Type_XVIII.yaml |
93.5% | 95.6% | 58/62 | |
Osteogenesis_Imperfecta_Type_XXII.yaml |
93.5% | 95.6% | 58/62 | |
Pilocytic_Astrocytoma.yaml |
93.5% | 95.4% | 87/93 | |
46_XY_DSD_Due_to_17_Beta_Hydroxysteroid_Dehydrogenase_3_Deficiency.yaml |
93.6% | 94.2% | 131/140 | |
Feingold_Syndrome.yaml |
93.6% | 94.6% | 131/140 | |
FG_Syndrome_1.yaml |
93.6% | 94.5% | 335/358 | |
Collagenous_Sprue.yaml |
93.6% | 96.6% | 102/109 | |
Hypersensitivity_Pneumonitis.yaml |
93.6% | 94.2% | 102/109 | 1 |
Immunoskeletal_Dysplasia_with_Neurodevelopmental_Abnormalities.yaml |
93.6% | 94.5% | 248/265 | |
Cor_Pulmonale.yaml |
93.6% | 95.1% | 73/78 | 1 |
Carotid_Web.yaml |
93.6% | 95.3% | 44/47 | 1 |
North_Carolina_Macular_Dystrophy.yaml |
93.6% | 95.1% | 88/94 | |
22q11.2_Deletion_Syndrome.yaml |
93.6% | 94.8% | 162/173 | |
Hurler_syndrome.yaml |
93.6% | 94.8% | 162/173 | |
Graves_Disease.yaml |
93.7% | 93.9% | 251/268 | 2 |
Parvovirus_B19_Infection.yaml |
93.7% | 93.4% | 133/142 | 1 |
oligoastrocytoma.yaml |
93.7% | 95.2% | 74/79 | |
Histiocytoid_Cardiomyopathy.yaml |
93.7% | 93.9% | 237/253 | 1 |
Hypertrophic_Cardiomyopathy.yaml |
93.7% | 93.1% | 268/286 | 2 |
Congenital_Isolated_Hyperinsulinism.yaml |
93.8% | 95.7% | 120/128 | |
Dengue.yaml |
93.8% | 100.0% | 15/16 | |
GM1_Gangliosidosis_Type_2.yaml |
93.8% | 95.9% | 90/96 | |
Infectious_Disease.yaml |
93.8% | 100.0% | 15/16 | |
Metastatic_Ovarian_Cancer.yaml |
93.8% | 94.8% | 75/80 | |
Osteogenesis_Imperfecta_Type_XII.yaml |
93.8% | 95.7% | 60/64 | |
Kosaki_Overgrowth_Syndrome.yaml |
93.8% | 95.0% | 91/97 | |
MERTK-Related_Retinopathy.yaml |
93.8% | 95.5% | 91/97 | |
Acute_Hypotension.yaml |
93.8% | 95.6% | 76/81 | |
Liddle_Syndrome.yaml |
93.9% | 94.5% | 168/179 | |
TANGO2_Deficiency_Disorder.yaml |
93.9% | 94.3% | 321/342 | |
Scabies.yaml |
93.9% | 95.4% | 46/49 | |
Parathyroid_Hyperplasia.yaml |
93.9% | 96.7% | 108/115 | |
COQ4-Related_Neonatal_Encephalomyopathy.yaml |
93.9% | 94.8% | 201/214 | |
Guillain_Barre_Syndrome.yaml |
93.9% | 95.0% | 93/99 | |
Plasma_Cell_Neoplasm.yaml |
93.9% | 95.2% | 124/132 | |
Splenic_Marginal_Zone_Lymphoma.yaml |
93.9% | 95.1% | 155/165 | |
Woodhouse-Sakati_Syndrome.yaml |
93.9% | 94.8% | 124/132 | |
Measles.yaml |
94.0% | 95.7% | 78/83 | |
Craniopharyngioma.yaml |
94.0% | 94.9% | 172/183 | |
Sjogrens_Syndrome.yaml |
94.0% | 95.1% | 172/183 | |
AFG2A-Related_Encephalopathy.yaml |
94.0% | 93.9% | 219/233 | 1 |
Alpha-gal_Syndrome.yaml |
94.0% | 95.4% | 94/100 | |
SEPSECS_Deficiency.yaml |
94.0% | 96.3% | 47/50 | |
Thromboangiitis_Obliterans.yaml |
94.0% | 95.3% | 110/117 | |
ANK2_Ankyrin_B_Syndrome.yaml |
94.0% | 95.5% | 63/67 | |
Osteogenesis_Imperfecta_Type_X.yaml |
94.0% | 95.9% | 63/67 | |
Osteogenesis_Imperfecta_Type_XX.yaml |
94.0% | 95.9% | 63/67 | |
Glutathione_Synthetase_Deficiency.yaml |
94.1% | 95.2% | 95/101 | |
Pancreatic_Mucinous_Cystadenoma.yaml |
94.1% | 95.3% | 95/101 | |
ATTR_Amyloidosis.yaml |
94.1% | 94.7% | 206/219 | |
adrenoleukodystrophy.yaml |
94.1% | 94.8% | 207/220 | |
46_XY_DSD_Due_to_5_Alpha_Reductase_2_Deficiency.yaml |
94.1% | 94.7% | 144/153 | |
Lymphoma.yaml |
94.1% | 93.5% | 32/34 | 1 |
Myelodysplastic_Syndrome.yaml |
94.1% | 95.6% | 96/102 | |
Okur_Chung_neurodevelopmental_syndrome.yaml |
94.1% | 95.1% | 96/102 | |
Osteogenesis_Imperfecta_Type_XI.yaml |
94.1% | 96.1% | 64/68 | |
Osteogenesis_Imperfecta_Type_XVI.yaml |
94.1% | 95.9% | 64/68 | |
Chung-Jansen_Syndrome.yaml |
94.1% | 94.7% | 305/324 | 1 |
Fibrochondrogenesis.yaml |
94.2% | 94.9% | 145/154 | |
Pancreatic_Agenesis.yaml |
94.2% | 95.5% | 97/103 | |
Chickenpox.yaml |
94.2% | 94.0% | 146/155 | 1 |
Mumps.yaml |
94.2% | 96.0% | 65/69 | |
Travelers_Diarrhea.yaml |
94.2% | 96.3% | 65/69 | |
Autosomal_Recessive_Multiple_Pterygium_Syndrome.yaml |
94.2% | 95.4% | 98/104 | |
Brachyphalangy_Polydactyly_Tibial_Aplasia_Syndrome.yaml |
94.2% | 95.2% | 98/104 | |
RP2-Related_Retinopathy.yaml |
94.3% | 95.8% | 82/87 | |
Lead_Poisoning.yaml |
94.3% | 95.2% | 263/279 | 1 |
ADGRG1_Bilateral_Frontoparietal_Polymicrogyria.yaml |
94.3% | 94.4% | 247/262 | 3 |
Osteogenesis_Imperfecta_Type_XVII.yaml |
94.3% | 96.2% | 66/70 | |
Relapsing_Polychondritis.yaml |
94.3% | 95.9% | 149/158 | |
Familial_Isolated_Vitamin_E_Deficiency.yaml |
94.3% | 95.7% | 100/106 | |
Inherited_Threoninemia.yaml |
94.4% | 95.7% | 117/124 | |
Congenital_Renal_Artery_Stenosis.yaml |
94.4% | 95.9% | 67/71 | |
Erythrokeratodermia_Variabilis.yaml |
94.4% | 95.8% | 67/71 | |
Osteogenesis_Imperfecta_Type_XIX.yaml |
94.4% | 96.2% | 67/71 | |
POEMS_Syndrome.yaml |
94.4% | 95.9% | 67/71 | |
Sagittal_Sinus_Thrombosis.yaml |
94.4% | 96.2% | 67/71 | |
Posterior_Polymorphous_Corneal_Dystrophy.yaml |
94.4% | 95.8% | 84/89 | |
Renal_Artery_Obstruction.yaml |
94.4% | 95.6% | 101/107 | |
Diffuse_Nonepidermolytic_Palmoplantar_Keratoderma.yaml |
94.4% | 94.8% | 135/143 | 1 |
AR_Cerebellar_Ataxia-Saccadic_Intrusion_Syndrome.yaml |
94.4% | 95.0% | 136/144 | |
Dentatorubral-Pallidoluysian_Atrophy.yaml |
94.4% | 95.0% | 119/126 | |
Familial_Renal_Glucosuria.yaml |
94.4% | 96.3% | 51/54 | |
Middle_East_Respiratory_Syndrome.yaml |
94.4% | 96.7% | 51/54 | |
Sclerosteosis.yaml |
94.4% | 96.1% | 102/108 | |
Tuberculosis.yaml |
94.5% | 94.8% | 222/235 | |
Ayme-Gripp_Syndrome.yaml |
94.5% | 94.2% | 120/127 | |
Noonan_Syndrome_with_Multiple_Lentigines.yaml |
94.5% | 95.2% | 120/127 | |
Preeclampsia.yaml |
94.5% | 95.5% | 172/182 | |
FOLR1-Related_Cerebral_Folate_Transport_Deficiency.yaml |
94.5% | 95.6% | 121/128 | |
Metachromatic_Leukodystrophy.yaml |
94.5% | 95.5% | 104/110 | |
Schindler_Disease.yaml |
94.5% | 96.6% | 52/55 | |
Migraine.yaml |
94.6% | 94.7% | 139/147 | |
Long_COVID.yaml |
94.6% | 94.4% | 470/497 | 3 |
Oppositional_Defiant_Disorder.yaml |
94.6% | 94.7% | 122/129 | |
Lung_Carcinoma.yaml |
94.6% | 93.9% | 35/37 | 1 |
Osteogenesis_Imperfecta_Type_XIII.yaml |
94.6% | 96.3% | 70/74 | |
Transaldolase_Deficiency.yaml |
94.6% | 94.8% | 210/222 | |
Tourette_Syndrome.yaml |
94.6% | 94.0% | 141/149 | 1 |
Hypomyelinating_Leukodystrophy_7.yaml |
94.7% | 96.0% | 89/94 | |
Menieres_Disease.yaml |
94.7% | 95.6% | 89/94 | |
Punctate_Palmoplantar_Keratoderma.yaml |
94.7% | 95.5% | 107/113 | |
IPEX_Syndrome.yaml |
94.7% | 95.8% | 125/132 | |
H_Syndrome.yaml |
94.7% | 96.0% | 161/170 | |
Humeroradial_Synostosis.yaml |
94.7% | 95.9% | 108/114 | |
Platelet-Type_von_Willebrand_Disease.yaml |
94.7% | 96.0% | 90/95 | |
Primary_Lateral_Sclerosis.yaml |
94.7% | 100.0% | 18/19 | |
VPS51-Related_Pontocerebellar_Hypoplasia-CDG.yaml |
94.7% | 96.4% | 72/76 | |
Leri-Weill_Dyschondrosteosis.yaml |
94.8% | 95.5% | 127/134 | |
Congenital_Myasthenic_Syndrome_6.yaml |
94.8% | 96.1% | 91/96 | |
GRIN2A-Related_Epileptic_Encephalopathy_and_Intellectual_Disability.yaml |
94.8% | 96.2% | 273/288 | |
Penile_Cancer.yaml |
94.8% | 96.0% | 91/96 | |
TTN_Related_Myopathy_Dominant_Negative_TTNsv.yaml |
94.8% | 96.0% | 91/96 | |
Adams-Oliver_Syndrome.yaml |
94.8% | 95.0% | 311/328 | |
Noonan_Syndrome.yaml |
94.8% | 94.9% | 477/503 | |
Dopa_Responsive_Dystonia.yaml |
94.8% | 95.9% | 92/97 | |
Juvenile_Sialidosis_Type_2.yaml |
94.9% | 96.5% | 74/78 | |
Metastatic_HCC.yaml |
94.9% | 95.7% | 93/98 | |
Wilsons_Disease.yaml |
94.9% | 94.7% | 614/647 | 3 |
Spasmodic_Dysphonia.yaml |
94.9% | 96.4% | 75/79 | |
Dermatomyositis.yaml |
94.9% | 95.8% | 244/257 | |
Anterior_Spinal_Artery_Syndrome.yaml |
95.0% | 95.2% | 151/159 | 1 |
Optic_Neuritis.yaml |
95.0% | 95.3% | 208/219 | |
Idiopathic_Spontaneous_Coronary_Artery_Dissection.yaml |
95.0% | 96.4% | 76/80 | |
Lupus_Nephritis.yaml |
95.0% | 96.4% | 95/100 | |
Malignant_Peripheral_Nerve_Sheath_Tumor.yaml |
95.0% | 95.9% | 114/120 | |
PDE6A-Related_Retinopathy.yaml |
95.0% | 96.3% | 76/80 | |
Refeeding_Syndrome.yaml |
95.0% | 95.9% | 171/180 | |
SYCP3-related_spermatogenic_failure.yaml |
95.0% | 96.9% | 57/60 | |
Transketolase_Deficiency.yaml |
95.0% | 96.7% | 57/60 | |
Hereditary_Pulmonary_Alveolar_Proteinosis.yaml |
95.0% | 95.9% | 134/141 | |
Carbamoyl_Phosphate_Synthetase_I_Deficiency.yaml |
95.0% | 95.6% | 230/242 | |
Autoimmune_Polyendocrinopathy.yaml |
95.1% | 95.2% | 231/243 | 1 |
Osteogenesis_Imperfecta_Type_XIV.yaml |
95.1% | 96.7% | 77/81 | |
Osteogenesis_Imperfecta_Type_XV.yaml |
95.1% | 96.7% | 77/81 | |
Meckel_Diverticulum.yaml |
95.1% | 96.2% | 58/61 | |
Cardiac_Valvular_Ehlers-Danlos_Syndrome.yaml |
95.1% | 96.6% | 97/102 | |
Multiple_System_Atrophy.yaml |
95.1% | 96.5% | 97/102 | |
Inborn_Disorder_of_Methionine_Cycle_and_Sulfur_Amino_Acid_Metabolism.yaml |
95.1% | 95.6% | 253/266 | |
Amyotrophic_Lateral_Sclerosis.yaml |
95.1% | 95.3% | 448/471 | 1 |
VLCAD_Deficiency.yaml |
95.1% | 95.5% | 234/246 | 1 |
3-Methylcrotonyl-CoA_Carboxylase_Deficiency.yaml |
95.1% | 95.3% | 176/185 | 1 |
Konzo.yaml |
95.2% | 96.5% | 79/83 | |
Methylmalonic_Acidemia.yaml |
95.2% | 95.9% | 297/312 | 1 |
Multiple_Acyl-CoA_Dehydrogenase_Deficiency.yaml |
95.2% | 95.7% | 258/271 | |
Fibromuscular_Dysplasia.yaml |
95.2% | 97.3% | 60/63 | |
STAT6_Gain_of_Function_Disease.yaml |
95.3% | 96.6% | 161/169 | |
Hereditary_Gingival_Fibromatosis.yaml |
95.3% | 96.1% | 121/127 | |
Spaceflight_Associated_Neuro-Ocular_Syndrome.yaml |
95.3% | 95.7% | 81/85 | |
DTYMK-Related_Neurodegeneration.yaml |
95.3% | 96.3% | 265/278 | |
Familial_Mediterranean_Fever.yaml |
95.3% | 94.9% | 143/150 | 3 |
Hypothalamic_Hamartoma_with_Gelastic_Seizures.yaml |
95.3% | 96.2% | 164/172 | |
THG1L-Related_Disorder.yaml |
95.4% | 97.2% | 103/108 | |
Arsenic_Related_Cancers.yaml |
95.4% | 95.4% | 268/281 | |
CNS_Vasculitis.yaml |
95.4% | 96.1% | 208/218 | |
EYS_Related_Retinitis_Pigmentosa.yaml |
95.4% | 96.6% | 104/109 | |
Pompe_Disease.yaml |
95.4% | 96.2% | 208/218 | |
ANK2_Related_Complex_Neurodevelopmental_Disorder.yaml |
95.5% | 97.1% | 63/66 | |
Fanconi-Bickel_Syndrome.yaml |
95.5% | 96.5% | 105/110 | |
Multisystemic_Smooth_Muscle_Dysfunction_Syndrome.yaml |
95.5% | 95.3% | 63/66 | 2 |
Semantic_Dementia.yaml |
95.5% | 100.0% | 21/22 | |
Snakebite_Envenoming.yaml |
95.5% | 100.0% | 21/22 | |
Hirschsprung_Disease.yaml |
95.5% | 95.9% | 127/133 | |
Rhizomelic_Chondrodysplasia_Punctata_Type_1.yaml |
95.5% | 96.3% | 127/133 | |
Perivascular_Epithelioid_Cell_Neoplasm.yaml |
95.5% | 96.8% | 85/89 | |
Primary_Cutaneous_Aggressive_Epidermotropic_CD8_T-cell_Lymphoma.yaml |
95.5% | 96.8% | 85/89 | |
Propionic_Acidemia.yaml |
95.5% | 96.2% | 234/245 | |
Leishmaniasis.yaml |
95.5% | 96.9% | 64/67 | |
Lymphatic_Filariasis.yaml |
95.5% | 96.8% | 64/67 | |
Hereditary_Methemoglobinemia.yaml |
95.6% | 96.3% | 129/135 | |
Osteogenesis_Imperfecta_Type_IX.yaml |
95.6% | 97.0% | 86/90 | |
Combined_Malonic_and_Methylmalonic_Aciduria.yaml |
95.6% | 97.0% | 65/68 | |
Metastatic_Gastric_Cancer.yaml |
95.6% | 97.0% | 65/68 | |
Tetanus.yaml |
95.6% | 95.2% | 65/68 | 1 |
Rabies.yaml |
95.6% | 96.5% | 239/250 | |
Noma.yaml |
95.6% | 96.8% | 87/91 | |
L1_Syndrome.yaml |
95.6% | 96.7% | 109/114 | |
Cystic_Echinococcosis.yaml |
95.7% | 97.5% | 44/46 | |
Dientamoebiasis.yaml |
95.7% | 96.9% | 132/138 | |
Primary_Progressive_Aphasia.yaml |
95.7% | 100.0% | 22/23 | |
Pemphigus_Vulgaris.yaml |
95.7% | 96.6% | 133/139 | |
Pseudoxanthoma_Elasticum.yaml |
95.7% | 96.6% | 111/116 | |
Torsade_De_Pointes_Syndrome_With_Short_Coupling_Interval.yaml |
95.7% | 96.9% | 111/116 | |
Choriocarcinoma.yaml |
95.7% | 96.5% | 289/302 | |
Conduct_Disorder.yaml |
95.7% | 95.8% | 156/163 | |
Osteochondritis_of_Tarsal_Metatarsal_Bone.yaml |
95.7% | 97.3% | 67/70 | |
Trimethylaminuria.yaml |
95.7% | 97.2% | 67/70 | |
Atypical_Teratoid_Rhabdoid_Tumor.yaml |
95.7% | 96.6% | 90/94 | |
RNU12-related_Minor_Spliceopathy.yaml |
95.7% | 97.9% | 45/47 | |
Trehalase_Deficiency.yaml |
95.7% | 97.9% | 45/47 | |
Breast_Implant_Associated_Anaplastic_Large_Cell_Lymphoma.yaml |
95.8% | 95.0% | 68/71 | 2 |
Post-Traumatic_Stress_Disorder.yaml |
95.8% | 96.0% | 136/142 | |
Rubella.yaml |
95.8% | 97.4% | 68/71 | |
SECISBP2_Deficiency.yaml |
95.8% | 97.4% | 68/71 | |
Sensory_Ataxic_Neuropathy_Dysarthria_Ophthalmoparesis.yaml |
95.8% | 97.9% | 68/71 | |
Delayed_Sleep_Phase_Syndrome.yaml |
95.8% | 97.9% | 91/95 | |
MPI-Congenital_Disorder_of_Glycosylation.yaml |
95.8% | 96.2% | 298/311 | |
Cushings_Syndrome.yaml |
95.8% | 98.1% | 46/48 | |
NDP_Related_Vitreoretinopathy.yaml |
95.8% | 98.0% | 46/48 | |
Beta-Ketothiolase_Deficiency.yaml |
95.9% | 96.1% | 301/314 | |
FAS-related_Autoimmune_Lymphoproliferative_Syndrome.yaml |
95.9% | 96.4% | 163/170 | |
Marden-Walker_Syndrome.yaml |
95.9% | 97.5% | 70/73 | |
Roifman-syndrome.yaml |
95.9% | 97.2% | 70/73 | |
Pseudopseudohypoparathyroidism.yaml |
95.9% | 96.9% | 117/122 | |
Cardiospondylocarpofacial_Syndrome.yaml |
95.9% | 96.0% | 283/295 | |
Complete_Androgen_Insensitivity_Syndrome.yaml |
95.9% | 96.4% | 213/222 | |
Mevalonate_Kinase_Deficiency.yaml |
96.0% | 97.1% | 119/124 | |
CANVAS.yaml |
96.0% | 97.0% | 167/174 | |
Sitosterolemia.yaml |
96.0% | 97.1% | 167/174 | |
Arthrogryposis-Renal_Dysfunction-Cholestasis_Syndrome.yaml |
96.0% | 96.5% | 312/325 | 1 |
Northern_Epilepsy.yaml |
96.0% | 98.1% | 48/50 | |
Spinal_Cord_Ischemia.yaml |
96.0% | 96.1% | 72/75 | 1 |
Hyperinsulinemic_Hypoglycemia.yaml |
96.0% | 95.8% | 412/429 | 2 |
RPE65-Related_Retinopathy.yaml |
96.0% | 97.2% | 97/101 | |
Krabbe_Disease.yaml |
96.0% | 96.9% | 170/177 | |
Carnitine_Palmitoyltransferase_II_Deficiency.yaml |
96.1% | 97.1% | 269/280 | 1 |
Congenital_Hypothyroidism.yaml |
96.1% | 96.7% | 196/204 | |
Hypotrichosis_with_Juvenile_Macular_Dystrophy.yaml |
96.1% | 96.8% | 148/154 | |
SCAD_Deficiency.yaml |
96.1% | 96.2% | 124/129 | |
Adult_Refsum_Disease.yaml |
96.1% | 96.5% | 298/310 | |
Hyperprolinemia_Type_2.yaml |
96.1% | 97.3% | 149/155 | |
Glycogen_Storage_Disease_Type_I.yaml |
96.1% | 96.5% | 299/311 | 1 |
Acoustic_Neuroma.yaml |
96.2% | 96.1% | 150/156 | 2 |
Acquired_Thrombotic_Thrombocytopenic_Purpura.yaml |
96.2% | 96.5% | 200/208 | |
Eosinophilic_Granulomatosis_with_Polyangiitis.yaml |
96.2% | 96.5% | 175/182 | |
Kikuchi-Fujimoto_Disease.yaml |
96.2% | 97.3% | 101/105 | |
Musculocontractural_Ehlers-Danlos_Syndrome.yaml |
96.2% | 97.3% | 253/263 | |
Mycosis_Fungoides.yaml |
96.2% | 97.0% | 102/106 | 1 |
Nonketotic_Hyperglycinemia.yaml |
96.2% | 97.0% | 204/212 | |
Cri-du-Chat_Syndrome.yaml |
96.3% | 97.4% | 232/241 | |
Genitopatellar_Syndrome.yaml |
96.3% | 97.3% | 104/108 | |
Cerebellar_Ataxia_Intellectual_Disability_and_Dysequilibrium.yaml |
96.3% | 97.5% | 105/109 | |
Meacham_syndrome.yaml |
96.3% | 97.1% | 105/109 | |
Partial_Androgen_Insensitivity_Syndrome.yaml |
96.3% | 96.7% | 237/246 | |
Hospital-Acquired_Acute_Kidney_Injury.yaml |
96.4% | 97.2% | 132/137 | |
COA3-Related_COX_Deficiency.yaml |
96.4% | 98.1% | 53/55 | |
Glomus_Tumor.yaml |
96.4% | 97.1% | 265/275 | |
Arts_syndrome.yaml |
96.4% | 97.5% | 160/166 | |
Facioscapulohumeral_Muscular_Dystrophy.yaml |
96.4% | 97.5% | 80/83 | |
Adenine_Phosphoribosyltransferase_Deficiency.yaml |
96.4% | 96.3% | 294/305 | |
Schneckenbecken_Dysplasia.yaml |
96.4% | 97.3% | 188/195 | |
MPDU1-congenital_disorder_of_glycosylation.yaml |
96.4% | 97.0% | 189/196 | |
Liberfarb_syndrome.yaml |
96.5% | 97.7% | 82/85 | |
Noonan_Syndrome-like_Disorder_with_Loose_Anagen_Hair.yaml |
96.5% | 97.9% | 82/85 | |
IRX5-related_Craniofacial_Dysostosis_with_Osteopenia_Intellectual_Disability_and_Dental_Anomalies.yaml |
96.5% | 96.3% | 110/114 | 1 |
PRKN-Related_Juvenile_Parkinson_Disease.yaml |
96.5% | 96.8% | 193/200 | 1 |
Lane_Hamilton_Syndrome.yaml |
96.5% | 98.5% | 83/86 | |
Oculofaciocardiodental_Syndrome.yaml |
96.6% | 97.7% | 196/203 | |
Acute_Myeloid_Leukemia_with_CEBPA_Somatic_Mutations.yaml |
96.6% | 97.7% | 253/262 | |
Amyloidosis.yaml |
96.6% | 97.6% | 113/117 | |
SLC35A2-CDG.yaml |
96.6% | 97.9% | 85/88 | |
Metaphyseal_Chondrodysplasia_Schmid_Type.yaml |
96.6% | 97.4% | 142/147 | |
Cleidocranial_Dysplasia.yaml |
96.6% | 98.2% | 114/118 | |
Friedreich_Ataxia.yaml |
96.6% | 97.0% | 286/296 | |
Congenital_Total_Pulmonary_Venous_Return_Anomaly.yaml |
96.6% | 97.9% | 86/89 | |
Silver_Russell_Syndrome.yaml |
96.6% | 97.5% | 115/119 | |
Adult-Onset_Autosomal_Dominant_Demyelinating_Leukodystrophy.yaml |
96.6% | 97.0% | 173/179 | 2 |
COL11A2_Hearing_Loss.yaml |
96.7% | 97.1% | 58/60 | 1 |
Gitelman_Syndrome.yaml |
96.7% | 97.2% | 174/180 | |
Pulmonary_Veno_Occlusive_Disease_And_Or_Pulmonary_Capillary_Haemangiomatosis.yaml |
96.7% | 97.7% | 117/121 | |
Anti-NMDA_Receptor_Encephalitis.yaml |
96.7% | 97.6% | 176/182 | |
Hashimoto_Encephalopathy.yaml |
96.7% | 97.3% | 147/152 | |
Fabry_Disease.yaml |
96.7% | 97.4% | 414/428 | |
ECHS1_Deficiency.yaml |
96.7% | 96.9% | 89/92 | |
Cyclosporiasis.yaml |
96.7% | 97.5% | 119/123 | 1 |
Juvenile_Polyposis_Syndrome.yaml |
96.8% | 97.1% | 209/216 | |
Chronic_Neurovisceral_Acid_Sphingomyelinase_Deficiency.yaml |
96.8% | 98.4% | 60/62 | |
Progressive_Muscular_Atrophy.yaml |
96.8% | 98.5% | 60/62 | |
Inborn_Disorder_of_Bile_Acid_Synthesis.yaml |
96.8% | 97.8% | 121/125 | |
Primary_Pigmented_Nodular_Adrenocortical_Disease.yaml |
96.8% | 97.8% | 121/125 | |
Kallmann_Syndrome.yaml |
96.8% | 98.0% | 91/94 | |
Dimethylglycine_Dehydrogenase_Deficiency.yaml |
96.8% | 98.4% | 122/126 | |
Isovaleric_Acidemia.yaml |
96.8% | 97.2% | 244/252 | |
ARX-Related_Lissencephaly_and_Interneuronopathy.yaml |
96.8% | 97.2% | 275/284 | 1 |
Peters_Plus_Syndrome.yaml |
96.8% | 97.7% | 214/221 | |
Scimitar_Syndrome.yaml |
96.9% | 97.7% | 123/127 | |
PRPS1_Deficiency_Spectrum.yaml |
96.9% | 97.4% | 185/191 | |
Infantile_Parkinsonism-Dystonia.yaml |
96.9% | 98.1% | 93/96 | |
Schnitzler_Syndrome.yaml |
96.9% | 98.4% | 93/96 | |
Adult_Polyglucosan_Body_Disease.yaml |
96.9% | 97.4% | 219/226 | |
ABCC9-Related_Intellectual_Disability_and_Myopathy_Syndrome.yaml |
96.9% | 97.7% | 282/291 | |
Cleft_Lip_Palate.yaml |
96.9% | 98.0% | 94/97 | |
Melkersson_Rosenthal_syndrome.yaml |
96.9% | 98.7% | 94/97 | |
Acute_Annular_Outer_Retinopathy.yaml |
96.9% | 96.6% | 157/162 | 1 |
Hemochromatosis.yaml |
96.9% | 97.2% | 317/327 | |
Beckwith-Wiedemann_Syndrome.yaml |
97.0% | 97.7% | 160/165 | |
Glucose-Galactose_Malabsorption.yaml |
97.0% | 98.6% | 64/66 | |
Antiphospholipid_Syndrome.yaml |
97.0% | 96.2% | 355/366 | 2 |
Glycogen_Storage_Disease_Type_IV.yaml |
97.0% | 97.4% | 292/301 | |
Tyrosinemia_Type_II.yaml |
97.0% | 98.5% | 65/67 | |
Combined_Pituitary_Hormone_Deficiencies_Genetic_Form.yaml |
97.0% | 97.7% | 163/168 | |
Bells_Palsy.yaml |
97.0% | 98.1% | 131/135 | |
Ludwigs_Angina.yaml |
97.0% | 97.9% | 131/135 | |
Isolated_Woolly_Hair.yaml |
97.1% | 98.6% | 67/69 | |
Rosacea.yaml |
97.1% | 98.1% | 268/276 | |
Hartnup_Disease.yaml |
97.1% | 97.6% | 237/244 | |
Citrullinemia_Type_I.yaml |
97.1% | 97.5% | 271/279 | |
Carbonic_Anhydrase_VA_Deficiency.yaml |
97.1% | 98.7% | 68/70 | |
Chondrodysplasia_Punctata_Tibial-metacarpal_Type.yaml |
97.1% | 98.2% | 102/105 | |
Holocarboxylase_Synthetase_Deficiency.yaml |
97.1% | 97.4% | 272/280 | 1 |
Ataxia_Telangiectasia.yaml |
97.2% | 97.6% | 274/282 | |
AIP-related_pituitary_adenoma_predisposition.yaml |
97.2% | 98.2% | 206/212 | |
Larsen_Syndrome.yaml |
97.2% | 98.5% | 103/106 | |
Giant_Cell_Arteritis.yaml |
97.2% | 98.1% | 138/142 | |
Neuronal_Ceroid_Lipofuscinosis.yaml |
97.2% | 98.0% | 139/143 | |
3-Phosphoglycerate_Dehydrogenase_Deficiency.yaml |
97.2% | 97.9% | 244/251 | |
Breast_Fibroadenoma.yaml |
97.2% | 100.0% | 35/36 | |
RHO-Related_Retinopathy.yaml |
97.2% | 98.2% | 106/109 | |
Neuromyelitis_Optica_Spectrum_Disorder.yaml |
97.3% | 97.5% | 71/73 | 1 |
Obesity_Due_to_MC4R_Pathway_Disruption.yaml |
97.3% | 98.2% | 107/110 | |
Achromatopsia.yaml |
97.3% | 96.9% | 250/257 | 1 |
Neuropsychiatric_SLE.yaml |
97.3% | 98.2% | 215/221 | |
Carnitine_Palmitoyltransferase_1A_Deficiency.yaml |
97.3% | 98.0% | 144/148 | |
Hypotonia-Cystinuria_Syndrome.yaml |
97.3% | 97.9% | 180/185 | |
MSMO1_Deficiency.yaml |
97.3% | 98.0% | 326/335 | |
N-Acetylglutamate_Synthase_Deficiency.yaml |
97.3% | 97.8% | 218/224 | |
Uterine_Leiomyoma.yaml |
97.3% | 98.4% | 109/112 | |
FOXE3_Anterior_Segment_Dysgenesis.yaml |
97.4% | 98.6% | 74/76 | |
Membranous_Nephropathy.yaml |
97.4% | 98.3% | 111/114 | |
Adrenal_Cortex_Adenoma.yaml |
97.4% | 97.7% | 339/348 | |
2-Methylbutyryl-CoA_Dehydrogenase_Deficiency.yaml |
97.4% | 98.2% | 190/195 | |
Frontonasal_Dysplasia.yaml |
97.4% | 98.8% | 76/78 | |
Kufor-Rakeb_syndrome.yaml |
97.4% | 98.4% | 114/117 | |
Pycnodysostosis.yaml |
97.4% | 98.2% | 152/156 | |
CKD-Mineral_Bone_Disorder.yaml |
97.5% | 98.4% | 269/276 | |
Burkitt_Lymphoma.yaml |
97.5% | 99.2% | 117/120 | |
CDH23-associated_pituitary_adenoma_5.yaml |
97.5% | 100.0% | 39/40 | |
Foodborne_Trematodiases.yaml |
97.5% | 100.0% | 39/40 | |
Hepatoblastoma.yaml |
97.5% | 99.1% | 117/120 | |
Bosch-Boonstra-Schaaf_Optic_Atrophy_Syndrome.yaml |
97.5% | 97.6% | 235/241 | |
Zellweger_Spectrum_Disorders.yaml |
97.5% | 98.1% | 196/201 | |
SUFU-related_Nevoid_Basal_Cell_Carcinoma_Syndrome.yaml |
97.5% | 98.7% | 79/81 | |
GM3_Synthase_Deficiency.yaml |
97.5% | 98.0% | 199/204 | |
Arteriosclerotic_Retinopathy.yaml |
97.6% | 100.0% | 40/41 | |
Homocystinuria.yaml |
97.6% | 97.8% | 405/415 | |
Spondyloepimetaphyseal_Dysplasia_Bieganski_Type.yaml |
97.6% | 98.9% | 122/125 | |
Mucolipidosis_Type_III_Alpha_Beta.yaml |
97.6% | 98.0% | 331/339 | |
Bachmann-Bupp_Syndrome.yaml |
97.7% | 98.3% | 295/302 | |
Adult_T_Cell_Leukemia_Lymphoma.yaml |
97.8% | 98.8% | 174/178 | |
Grange_syndrome.yaml |
97.8% | 98.9% | 87/89 | |
Bacterial_meningitis.yaml |
97.8% | 98.1% | 263/269 | |
Shashi_X-Linked_Intellectual_Disability_Syndrome.yaml |
97.8% | 98.7% | 132/135 | |
Gilberts_Syndrome.yaml |
97.8% | 98.8% | 90/92 | |
ADNP-Related_Syndrome.yaml |
97.9% | 98.1% | 320/327 | 2 |
BRPF1-Related_Intellectual_Disability.yaml |
97.9% | 98.2% | 413/422 | 1 |
CHD2-Related_Developmental_and_Epileptic_Encephalopathy.yaml |
97.9% | 99.1% | 139/142 | |
Hepatitis_B.yaml |
97.9% | 97.9% | 232/237 | |
Raine_Syndrome.yaml |
97.9% | 98.5% | 280/286 | |
Arboleda-Tham_Syndrome.yaml |
97.9% | 98.2% | 187/191 | 1 |
EEFSEC_Deficiency.yaml |
97.9% | 100.0% | 47/48 | |
Familial_Focal_Epilepsy_With_Variable_Foci.yaml |
97.9% | 99.0% | 94/96 | |
FOXP1_Syndrome.yaml |
97.9% | 98.4% | 382/390 | 1 |
Nemaline_Myopathy.yaml |
98.0% | 98.0% | 288/294 | |
Takayasu_Arteritis.yaml |
98.0% | 98.6% | 240/245 | |
Arterial_Calcification_of_Infancy.yaml |
98.0% | 98.6% | 145/148 | |
Congenital_Sucrase-Isomaltase_Deficiency.yaml |
98.0% | 98.9% | 146/149 | |
SLC45A1-Related_Neuronal_Glucose_Transporter_Deficiency.yaml |
98.0% | 100.0% | 49/50 | |
46_XX_Testicular_DSD.yaml |
98.0% | 98.4% | 247/252 | |
X-linked_Agammaglobulinemia.yaml |
98.1% | 99.1% | 101/103 | |
ornithine_aminotransferase_deficiency.yaml |
98.1% | 98.7% | 152/155 | |
Polycystic_Echinococcosis.yaml |
98.1% | 100.0% | 51/52 | |
Southern_Tick-Associated_Rash_Illness.yaml |
98.1% | 100.0% | 51/52 | |
Cat-Scratch_Disease.yaml |
98.1% | 98.2% | 103/105 | 1 |
Ethylmalonic_Encephalopathy.yaml |
98.1% | 99.1% | 103/105 | |
ALK_Rearranged_NSCLC.yaml |
98.1% | 99.3% | 156/159 | |
Limb-Girdle_Muscular_Dystrophy_Autosomal_Dominant.yaml |
98.1% | 99.1% | 105/107 | |
Apparent_Mineralocorticoid_Excess.yaml |
98.1% | 99.1% | 106/108 | |
Menkes_Disease.yaml |
98.1% | 98.3% | 212/216 | |
Schistosomiasis.yaml |
98.1% | 100.0% | 53/54 | |
Maple_Syrup_Urine_Disease.yaml |
98.2% | 98.5% | 321/327 | |
Hairy_Cell_Leukemia.yaml |
98.2% | 99.4% | 108/110 | |
EFL1-related_Shwachman-Diamond_syndrome.yaml |
98.2% | 99.1% | 110/112 | |
PGM2L1_Deficiency.yaml |
98.2% | 100.0% | 55/56 | |
Jeavons_Syndrome.yaml |
98.2% | 99.1% | 111/113 | |
Cowden_Syndrome.yaml |
98.2% | 98.9% | 167/170 | |
3-Hydroxy-3-Methylglutaryl-CoA_Synthase_Deficiency.yaml |
98.2% | 98.5% | 224/228 | 1 |
Congenital_Epulis.yaml |
98.2% | 100.0% | 56/57 | |
Tetrahydrobiopterin_Deficiency.yaml |
98.3% | 98.9% | 172/175 | |
Livedoid_Vasculopathy.yaml |
98.3% | 100.0% | 58/59 | |
Retrograde_Cricopharyngeus_Dysfunction.yaml |
98.3% | 100.0% | 58/59 | |
Sifrim-Hitz-Weiss_Syndrome.yaml |
98.3% | 99.2% | 116/118 | |
Arthrogryposis_Multiplex_Congenita.yaml |
98.3% | 98.5% | 117/119 | 1 |
RPGR-Related_Retinopathy.yaml |
98.3% | 99.2% | 117/119 | |
Coccidioidomycosis.yaml |
98.3% | 99.3% | 176/179 | |
L-2-Hydroxyglutaric_Aciduria.yaml |
98.3% | 98.8% | 236/240 | |
Hereditary_Fructose_Intolerance.yaml |
98.3% | 98.9% | 178/181 | |
Age_Related_Macular_Degeneration.yaml |
98.4% | 98.8% | 179/182 | 1 |
Axenfeld-Rieger_syndrome.yaml |
98.4% | 98.7% | 185/188 | 1 |
Hemophagocytic_Lymphohistiocytosis.yaml |
98.4% | 99.2% | 125/127 | |
Stiff_Person_Syndrome.yaml |
98.4% | 99.0% | 189/192 | |
Myeloproliferative_Neoplasm_Unclassifiable.yaml |
98.5% | 100.0% | 65/66 | |
Idiopathic_Phalangeal_Acro-osteolysis.yaml |
98.5% | 100.0% | 66/67 | |
Prune_Belly_Syndrome.yaml |
98.5% | 98.6% | 199/202 | 1 |
COL11A2_Skeletal_Spectrum.yaml |
98.5% | 98.8% | 134/136 | 1 |
Carnitine-Acylcarnitine_Translocase_Deficiency.yaml |
98.6% | 99.2% | 272/276 | |
Osteosarcoma.yaml |
98.6% | 98.3% | 138/140 | 1 |
Acute_Megakaryoblastic_Leukemia.yaml |
98.6% | 99.2% | 346/351 | |
MCAD_Deficiency.yaml |
98.6% | 99.1% | 208/211 | |
Akinetopsia.yaml |
98.6% | 100.0% | 70/71 | |
FGFR1_Hypogonadotropic_Hypogonadism.yaml |
98.6% | 99.3% | 141/143 | |
Amyotrophic_Lateral_Sclerosis-Parkinsonism-Dementia_Complex.yaml |
98.6% | 99.1% | 142/144 | 1 |
Visual_Snow_Syndrome.yaml |
98.6% | 100.0% | 71/72 | |
CHRNA1-associated_Fetal_Hypo-akinesia_Disorder_of_Prenatal_Onset.yaml |
98.6% | 100.0% | 72/73 | |
Cholesteatoma.yaml |
98.6% | 99.1% | 217/220 | |
Congenital_Lactase_Deficiency.yaml |
98.6% | 100.0% | 73/74 | |
Mullegama-Klein-Martinez_Syndrome.yaml |
98.7% | 99.4% | 149/151 | |
MGAT2-congenital_disorder_of_glycosylation.yaml |
98.7% | 99.4% | 150/152 | |
Renal_Tubular_Acidosis_Distal_4_with_Hemolytic_Anemia.yaml |
98.7% | 99.3% | 151/153 | |
SETD5_Haploinsufficiency_Syndrome.yaml |
98.7% | 99.2% | 383/388 | |
Acute_Lymphoblastic_Leukemia.yaml |
98.7% | 99.6% | 233/236 | |
OTUD6B-Related_Neurodevelopmental_Disorder.yaml |
98.7% | 99.2% | 235/238 | |
Smith-Lemli-Opitz_syndrome.yaml |
98.7% | 99.3% | 157/159 | |
Pyruvate_Carboxylase_Deficiency_Disease.yaml |
98.8% | 99.4% | 158/160 | |
Schaaf-Yang_Syndrome.yaml |
98.8% | 99.2% | 237/240 | |
Peroxisome_Biogenesis_Disorder_4B.yaml |
98.8% | 99.0% | 159/161 | |
Cronkhite-Canada_syndrome.yaml |
98.8% | 100.0% | 80/81 | |
Hao-Fountain_syndrome.yaml |
98.8% | 100.0% | 80/81 | |
Houge-Janssens_Syndrome.yaml |
98.8% | 99.4% | 161/163 | |
Tyrosinemia_Type_I.yaml |
98.8% | 99.2% | 242/245 | |
Aspartylglucosaminuria.yaml |
98.8% | 98.9% | 323/327 | 2 |
Appendiceal_Neuroendocrine_Tumor.yaml |
98.8% | 100.0% | 81/82 | |
Arterial_Dissection_Lentiginosis_Syndrome.yaml |
98.8% | 100.0% | 81/82 | |
Brain_Small_Vessel_Disease_1_With_Or_Without_Ocular_Anomalies.yaml |
98.8% | 99.4% | 162/164 | |
Agnathia-Otocephaly_Complex.yaml |
98.8% | 99.0% | 328/332 | |
Peroxisome_Biogenesis_Disorder_1B.yaml |
98.8% | 99.0% | 164/166 | |
Waldenstrom_Macroglobulinemia.yaml |
98.8% | 100.0% | 82/83 | |
Anaplastic_Large_Cell_Lymphoma.yaml |
98.8% | 98.8% | 166/168 | 1 |
Sialidosis_Type_1.yaml |
98.8% | 99.2% | 250/253 | |
Spondylodysplastic_Ehlers-Danlos_Syndrome.yaml |
98.8% | 99.2% | 250/253 | |
Pyruvate_Dehydrogenase_Deficiency.yaml |
98.8% | 99.0% | 504/510 | |
Epidermolysis_Bullosa.yaml |
98.8% | 99.1% | 254/257 | |
Hereditary_Diffuse_Leukoencephalopathy_with_Spheroids.yaml |
98.8% | 100.0% | 85/86 | |
X-linked_Nonsyndromic_Hearing_Loss.yaml |
98.8% | 100.0% | 85/86 | |
Atelosteogenesis_Type_III.yaml |
98.8% | 99.4% | 171/173 | |
Wolman_Disease.yaml |
98.9% | 99.5% | 172/174 | |
Landau-Kleffner_Syndrome.yaml |
98.9% | 100.0% | 87/88 | |
Lesch-Nyhan_Syndrome.yaml |
98.9% | 99.2% | 262/265 | |
Hereditary_Orotic_Aciduria.yaml |
98.9% | 99.4% | 177/179 | |
ALG1-Congenital_Disorder_of_Glycosylation.yaml |
98.9% | 100.0% | 91/92 | |
Atelosteogenesis_Type_II.yaml |
98.9% | 99.0% | 276/279 | 1 |
PRPH2-Related_Retinopathy.yaml |
99.0% | 100.0% | 95/96 | |
Alpha_Mannosidosis.yaml |
99.0% | 99.2% | 476/481 | |
Blepharophimosis_Intellectual_Disability_Syndrome_MKB_Type.yaml |
99.0% | 100.0% | 96/97 | |
Atelosteogenesis_Type_I.yaml |
99.0% | 99.5% | 193/195 | |
Adenosine_Kinase_Deficiency.yaml |
99.0% | 99.5% | 199/201 | |
Achoo_Syndrome.yaml |
99.0% | 100.0% | 100/101 | |
Acrocallosal_Syndrome.yaml |
99.0% | 99.5% | 202/204 | |
MEDNIK_syndrome.yaml |
99.0% | 100.0% | 101/102 | |
Hunter_syndrome.yaml |
99.0% | 99.5% | 203/205 | |
Chronic_Myelomonocytic_Leukemia.yaml |
99.0% | 100.0% | 103/104 | |
Hereditary_Intrinsic_Factor_Deficiency.yaml |
99.0% | 100.0% | 104/105 | |
Semicircular_Canal_Dehiscence_Syndrome.yaml |
99.0% | 99.0% | 208/210 | |
Achondrogenesis_Type_II.yaml |
99.1% | 99.5% | 211/213 | |
Meningioma.yaml |
99.1% | 99.0% | 211/213 | |
Farber_Disease.yaml |
99.1% | 99.5% | 213/215 | |
Cutaneous_Larva_Migrans.yaml |
99.1% | 100.0% | 107/108 | |
Acrodysostosis.yaml |
99.1% | 99.6% | 220/222 | |
Sanfilippo_syndrome.yaml |
99.1% | 99.6% | 221/223 | |
CRB1_Retinal_Dystrophies.yaml |
99.1% | 100.0% | 111/112 | |
Temtamy_Syndrome.yaml |
99.1% | 100.0% | 112/113 | |
Central_Congenital_Hypothyroidism.yaml |
99.1% | 100.0% | 113/114 | |
Mitochondrial_Neurogastrointestinal_Encephalomyopathy.yaml |
99.1% | 100.0% | 113/114 | |
Brown-Vialetto-Van_Laere_Syndrome.yaml |
99.1% | 100.0% | 115/116 | |
Myxedema.yaml |
99.1% | 100.0% | 116/117 | |
Morquio_syndrome.yaml |
99.1% | 99.6% | 233/235 | |
Autosomal_Dominant_Striatal_Neurodegeneration.yaml |
99.2% | 100.0% | 117/118 | |
Transverse_Myelitis.yaml |
99.2% | 100.0% | 117/118 | |
Acromesomelic_Dysplasia_Maroteaux_Type.yaml |
99.2% | 99.6% | 235/237 | |
Galactosemia.yaml |
99.2% | 99.6% | 235/237 | |
Anal_Canal_Adenocarcinoma.yaml |
99.2% | 100.0% | 118/119 | |
Stevens-Johnson_Syndrome.yaml |
99.2% | 99.6% | 239/241 | |
Adenovirus_Respiratory_Infection.yaml |
99.2% | 100.0% | 120/121 | |
CALFAN_Syndrome.yaml |
99.2% | 100.0% | 120/121 | |
X-linked_Dystonia-Parkinsonism.yaml |
99.2% | 100.0% | 120/121 | |
Anorexia_Nervosa.yaml |
99.2% | 99.3% | 242/244 | |
Autosomal_Recessive_Ataxia_Beauce_Type.yaml |
99.2% | 100.0% | 121/122 | |
Pars_Planitis.yaml |
99.2% | 100.0% | 121/122 | |
Activated_PI3K-delta_Syndrome.yaml |
99.2% | 99.5% | 243/245 | 1 |
Acetaminophen_Hepatotoxicity.yaml |
99.2% | 99.6% | 247/249 | |
Achondroplasia.yaml |
99.2% | 99.4% | 375/378 | 1 |
Aortic_Valve_Disease_2.yaml |
99.2% | 100.0% | 126/127 | |
STK4_Deficiency.yaml |
99.2% | 100.0% | 128/129 | |
Arterial_Tortuosity_Syndrome.yaml |
99.2% | 100.0% | 131/132 | |
Borderline_Personality_Disorder.yaml |
99.2% | 100.0% | 131/132 | |
Ainhum.yaml |
99.3% | 100.0% | 136/137 | |
Glycogen_Storage_Disease_XV.yaml |
99.3% | 100.0% | 137/138 | |
Acute_Lichenoid_Pityriasis.yaml |
99.3% | 99.6% | 278/280 | |
Acquired_Immunodeficiency_Syndrome.yaml |
99.3% | 100.0% | 141/142 | |
Body_Dysmorphic_Disorder.yaml |
99.3% | 100.0% | 143/144 | |
Anaplastic_Thyroid_Carcinoma.yaml |
99.3% | 100.0% | 145/146 | |
Lysinuric_Protein_Intolerance.yaml |
99.3% | 100.0% | 145/146 | |
AL_Amyloidosis.yaml |
99.3% | 99.7% | 292/294 | |
Chorea-acanthocytosis.yaml |
99.3% | 100.0% | 148/149 | |
Seborrheic_Dermatitis.yaml |
99.3% | 100.0% | 150/151 | |
ACAD9_Deficiency.yaml |
99.3% | 99.3% | 152/153 | |
Adult-Onset_Still_Disease.yaml |
99.4% | 100.0% | 153/154 | |
Fucosidosis.yaml |
99.4% | 99.7% | 306/308 | |
Neurodegeneration_With_Brain_Iron_Accumulation.yaml |
99.4% | 100.0% | 153/154 | |
Coffin_Siris_Syndrome.yaml |
99.4% | 99.7% | 307/309 | |
ALDH18A1_Cutis_Laxa.yaml |
99.4% | 100.0% | 157/158 | |
Acquired_Angioedema.yaml |
99.4% | 100.0% | 157/158 | |
BLOC1S1-related_Complex_Neurodevelopmental_Disorder_with_Leukodystrophy.yaml |
99.4% | 100.0% | 157/158 | |
Genetic_Developmental_and_Epileptic_Encephalopathy.yaml |
99.4% | 100.0% | 160/161 | |
Acatalasia.yaml |
99.4% | 100.0% | 162/163 | |
Arsenic_Poisoning.yaml |
99.4% | 100.0% | 164/165 | |
Leptospirosis.yaml |
99.4% | 99.4% | 332/334 | |
Lafora_Disease.yaml |
99.4% | 99.7% | 333/335 | |
Budd-Chiari_Syndrome.yaml |
99.4% | 100.0% | 168/169 | |
CHARGE_Syndrome.yaml |
99.4% | 100.0% | 168/169 | |
COFS_Syndrome.yaml |
99.4% | 100.0% | 168/169 | |
Glycogen_Storage_Disease_Type_VII.yaml |
99.4% | 100.0% | 168/169 | |
Bohring-Opitz_syndrome.yaml |
99.4% | 99.4% | 172/173 | |
BEST1-Related_Dominant_Retinopathy.yaml |
99.4% | 100.0% | 173/174 | |
MMACHC-related_Methylmalonic_Aciduria_and_Homocystinuria_cblC_Type.yaml |
99.4% | 100.0% | 173/174 | |
Sandhoff_Disease.yaml |
99.4% | 100.0% | 173/174 | |
CACNA1A_Related_Disorder.yaml |
99.4% | 100.0% | 174/175 | |
CD27-related_lymphoproliferative_and_immune_disorder.yaml |
99.4% | 100.0% | 174/175 | |
Acute_Hepatitis_C_Virus_Infection.yaml |
99.4% | 100.0% | 175/176 | |
BRAF_V600E_Mutant_NSCLC.yaml |
99.4% | 100.0% | 175/176 | |
Pontocerebellar_Hypoplasia.yaml |
99.4% | 100.0% | 177/178 | |
Spinocerebellar_Ataxia_Type_17.yaml |
99.4% | 100.0% | 177/178 | |
Limbic_Encephalitis.yaml |
99.5% | 100.0% | 181/182 | |
Clostridioides_difficile_Infection.yaml |
99.5% | 99.5% | 184/185 | |
Neurosarcoidosis.yaml |
99.5% | 100.0% | 184/185 | |
Cortisone_Reductase_Deficiency.yaml |
99.5% | 100.0% | 185/186 | |
COG7-Congenital_Disorder_of_Glycosylation.yaml |
99.5% | 100.0% | 188/189 | |
ATRX_Syndrome.yaml |
99.5% | 100.0% | 192/193 | |
ALG12_Congenital_Disorder_of_Glycosylation.yaml |
99.5% | 100.0% | 193/194 | |
Autosomal_Recessive_Cerebellar_Ataxia_With_Late_Onset_Spasticity.yaml |
99.5% | 100.0% | 193/194 | |
Susac_Syndrome.yaml |
99.5% | 100.0% | 195/196 | |
CADASIL_Type_1.yaml |
99.5% | 100.0% | 198/199 | |
Adult_Neuronal_Ceroid_Lipofuscinosis.yaml |
99.5% | 100.0% | 200/201 | |
Autoimmune_Autonomic_Ganglionopathy.yaml |
99.5% | 100.0% | 202/203 | |
ALG9-congenital_disorder_of_glycosylation.yaml |
99.5% | 100.0% | 203/204 | |
SETD1B-Related_Neurodevelopmental_Disorder.yaml |
99.5% | 100.0% | 204/205 | |
Asparagine_Synthetase_Deficiency.yaml |
99.5% | 100.0% | 207/208 | |
Aggressive_NK-cell_Leukemia.yaml |
99.5% | 100.0% | 212/213 | |
Amniotic_Band_Syndrome.yaml |
99.5% | 100.0% | 218/219 | |
AGAT_Deficiency.yaml |
99.5% | 100.0% | 221/222 | |
Agenesis_of_the_Corpus_Callosum_with_Peripheral_Neuropathy.yaml |
99.6% | 100.0% | 228/229 | |
Alkaptonuria.yaml |
99.6% | 100.0% | 228/229 | |
Autosomal_Recessive_Ataxia_Due_to_Ubiquinone_Deficiency.yaml |
99.6% | 100.0% | 228/229 | |
Biotin_Thiamine_Responsive_Basal_Ganglia_Disease.yaml |
99.6% | 100.0% | 228/229 | |
Paraneoplastic_Neurological_Syndromes.yaml |
99.6% | 100.0% | 247/248 | |
Acute_Disseminated_Encephalomyelitis.yaml |
99.6% | 100.0% | 252/253 | |
COG1-congenital_disorder_of_glycosylation.yaml |
99.6% | 100.0% | 252/253 | |
Cystinuria.yaml |
99.6% | 100.0% | 253/254 | |
ALDH18A1_De_Barsy_Spectrum.yaml |
99.6% | 100.0% | 254/255 | |
Aromatase_Deficiency.yaml |
99.6% | 100.0% | 255/256 | |
Tangier_Disease.yaml |
99.6% | 100.0% | 260/261 | |
APL_PML_RARA.yaml |
99.6% | 100.0% | 263/264 | |
Say-Barber-Biesecker-Young-Simpson_Syndrome.yaml |
99.6% | 100.0% | 263/264 | |
Acquired_Partial_Lipodystrophy.yaml |
99.6% | 100.0% | 268/269 | |
Berardinelli_Seip_Congenital_Lipodystrophy.yaml |
99.6% | 100.0% | 272/273 | |
Botulism.yaml |
99.7% | 99.7% | 296/297 | |
Adult_Onset_Dystonia_Parkinsonism.yaml |
99.7% | 100.0% | 308/309 | |
Stargardt_Disease.yaml |
99.7% | 99.7% | 320/321 | |
Acute_Intermittent_Porphyria.yaml |
99.7% | 100.0% | 331/332 | |
Biotinidase_Deficiency.yaml |
99.7% | 100.0% | 335/336 | |
Hyperornithinemia_Hyperammonemia_Homocitrullinuria_Syndrome.yaml |
99.7% | 100.0% | 345/346 | |
46_XX_Gonadal_Dysgenesis.yaml |
99.7% | 100.0% | 365/366 | |
46_XY_complete_gonadal_dysgenesis.yaml |
99.7% | 100.0% | 376/377 | |
Bosma_Arhinia_Microphthalmia_Syndrome.yaml |
99.7% | 99.6% | 387/388 | |
Autosomal_Recessive_Dopa_Responsive_Dystonia.yaml |
99.7% | 100.0% | 395/396 | |
Cerebrotendinous_Xanthomatosis.yaml |
99.8% | 100.0% | 433/434 | |
Acne_Vulgaris.yaml |
100.0% | 100.0% | 169/169 | |
Acute_Flaccid_Myelitis.yaml |
100.0% | 100.0% | 232/232 | |
Atrial_Septal_Defect.yaml |
100.0% | 100.0% | 210/210 | |
Attention_Deficit-Hyperactivity_Disorder.yaml |
100.0% | 100.0% | 170/170 | |
Auto-Brewery_Syndrome.yaml |
100.0% | 100.0% | 132/132 | |
Autoimmune_Hepatitis.yaml |
100.0% | 100.0% | 212/212 | |
Autoinflammation_Immune_Dysregulation_and_Eosinophilia.yaml |
100.0% | 100.0% | 220/220 | |
Autosomal_Dominant_Cerebellar_Ataxia_Type_I.yaml |
100.0% | 100.0% | 209/209 | |
Autosomal_Dominant_Cerebellar_Ataxia_Type_III.yaml |
100.0% | 100.0% | 185/185 | |
Autosomal_Dominant_Dopa_Responsive_Dystonia.yaml |
100.0% | 100.0% | 212/212 | |
Autosomal_Recessive_Primary_Microcephaly.yaml |
100.0% | 100.0% | 495/495 | |
BBSome-Related_Retinitis_Pigmentosa.yaml |
100.0% | 100.0% | 208/208 | |
BCKDK_Deficiency.yaml |
100.0% | 100.0% | 238/238 | |
BRAF_V600_Mutant_Melanoma.yaml |
100.0% | 100.0% | 236/236 | |
Babesiosis.yaml |
100.0% | 100.0% | 331/331 | |
Binge_Eating_Disorder.yaml |
100.0% | 100.0% | 117/117 | |
Bird_Fanciers_Lung.yaml |
100.0% | 100.0% | 273/273 | |
Blau_Syndrome.yaml |
100.0% | 100.0% | 236/236 | |
Bloom_Syndrome.yaml |
100.0% | 100.0% | 237/237 | |
Borjeson-Forssman-Lehmann_syndrome.yaml |
100.0% | 100.0% | 250/250 | |
Lynch_Syndrome.yaml |
100.0% | 100.0% | 227/227 | |
Machado_Joseph_Disease.yaml |
100.0% | 100.0% | 191/191 | |
SETBP1_Disorder.yaml |
100.0% | 100.0% | 84/84 | |
Thallium_Poisoning.yaml |
100.0% | 100.0% | 233/233 |
Tracking 1,827 curated entries, 96,992 evidence items, 74,281 ontology-grounded terms, and 10,245 pathophysiology nodes. Average weighted compliance is 89.8%. MONDO human-disease coverage includes 1,763 exact-page terms and 10,259 exact-or-parent represented terms.
Found 472 referenced MONDO disease terms without local pages across 516 linking page references.
24693 of 24693 MONDO candidates remain after accounting for 0 already curated diseases. Top remaining candidate: glioblastoma (79.5).